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ABSTRACT 
The term "genetic code" refers to the way in which the information encoded in nucleic acids 
is converted into the amino-acid sequence of proteins. There is however also a second genetic 
code, one that is used by the cells to read the blueprints of the entire organism. This second 
genetic code is composed of gene regulatory information that specifies how much of a gene 
product should be made when and where. This information is read primarily by sequence 
specific DNA binding proteins called transcription factors (TFs). TFs recognize and bind 
short DNA sequences that are located in the regions of DNA that are either just adjacent or 
relatively close to their target genes. When bound to these sites, TFs directly regulate 
transcription rates by recruiting the general transcription machinery, or by inhibiting its 
recruitment. Alternatively, TFs can influence transcription rates indirectly by recruiting 
proteins that will change the local chromatin environment in a way that will promote or 
inhibit transcription.  
Each TF has its target specificity, it binds to a range of similar sequences that can be ranked 
based on their relative binding strengths. A major gap in our understanding of life is the lack 
of knowledge of the TF DNA binding-specificities. While we have good estimates of the total 
number of TFs and their general types, we do not yet understand the way in which the gene 
regulatory instructions are encoded in the genome. To approach this important question, we 
first need to know which DNA sequences TFs bind and how strongly. 
The aim of this thesis project was to develop efficient methods for the characterization of TF 
binding specificities and then use these methods to catalogue DNA-binding specificities of as 
many human TFs as possible.  
In Study I, we converted the classical Systematic Evolution of Ligands by Exponential 
Enrichment (SELEX) assay into a high throughput compatible method (HT-SELEX) and 
showcased the method by analyzing DNA binding specificities of 18 TFs representing 14 
structural classes. Some of the results were validated by in vivo results from chromatin 
immunoprecipitation assays. 
In Study II, we used HT-SELEX to analyze the binding specificities for clones representing 
almost all human TFs, generating a dataset of high resolution DNA binding specificity 
models for more mammalian TFs than in the entire previously published literature combined. 
Another major feature of our dataset is its high consistency, which was achieved by 
performing all of the experiments in parallel with the same method.  
In Study III we studied evolution of gene regulation by analyzing the DNA binding 
specificities of TFs from the fruit fly Drosophila melanogaster. Analysis showed that even 
though the common ancestor of human and insects lived over 600 million years ago, the TF 
binding-specificities were very conserved between these species and there were similar 
counterparts to almost all of the TFs in either of the species.  
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1 Sequence specific transcription factors  
1.1 INTRODUCTION TO GENE REGULATION 
All life requires systems that regulate the amounts of their various protein- and RNA 
molecules, and they need to be able to respond to external stimuli by changing the amounts of 
these macromolecules. Products of the genes are either ribonucleic acid (RNA) molecules 
that are functional by themselves, such as ribosomal- or transfer RNAs, or they are messenger 
RNA (mRNAs) molecules that are subsequently transported out of the nucleus and translated 
into proteins.  
Most of the directly functional RNA molecules are general cellular components and mainly 
due to this their regulation is a much more simple process than that of many protein coding 
mRNAs. They are produced with dedicated RNA-polymerase I and III based regulatory 
systems, of which the RNA pol I centered system produces the large ribosomal RNAs1 and 
the RNA pol III based system makes most of the small RNA molecules such as transfer 
RNAs2. All of the protein coding genes and a subset of the functional RNA molecules are 
however made using RNA polymerase II, which is controlled through highly complex 
regulatory systems. 
Cells use multiple mechanisms to control their protein levels; 1) Are the gene regulatory 
elements accessible for the transcriptional machinery? 2) How often those accessible genes 
are read into mRNA? 3) How much of the produced mRNA reaches the ribosome and is 
translated to proteins? 4) And finally, the proteins have different stabilities and their number 
is often controlled through selective breakdown3.  
The first two stages are controlled mostly by sequence specific DNA binding proteins called 
transcription factors (TFs). TFs function by recognizing and binding to target sites that are 
located in gene regulatory regions, relatively closely to their target genes. Gene regulatory 
regions contain typically tens of target sites for multiple different TFs, and the regulatory 
outcome is determined by the combination of TFs that bind to it. TFs that increase the 
expression of their target genes are called activators and those that decrease it are called 
repressors. Both of them can operate through accessibility or expression rate based 
mechanisms. Some TFs recruit chromatin modifying protein complexes that remodel the 
local chromatin towards a more open or closed state, and others control the level of gene 
expression by recruiting components of the general transcriptional machinery to transcription 
start sites (TSS)3 
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Chromatin accessibility (chromatin state) based control is especially important for 
multicellular life, as many of the genes are relevant only to certain cell types. Consequently, 
much of the transcriptional regulation related to cell differentiation occurs at this level4,5. 
Control of the transcription rate on the other hand is not associated as strongly with cell 
differentiation, but more to dynamic control of cells functions and responses to external 
stimuli (Reviewed in6).  
Proteins need to be present in cells in suitable numbers, which varies enormously depending 
on the type of protein, and the cell type. While some proteins are expressed at very low 
numbers (tens to hundreds of copies per cell), others are expressed in scales of tens of 
millions7. In most of the cases the expression of wrong proteins would be just wasteful, but in 
other instances the misplaced expression of proteins, especially certain TFs, can lead to 
highly adverse outcomes such as reversal of cell differentiation or differentiation of the cell to 
a wrong lineage, which can then manifest in developmental defects or cancer. Thus, the gene 
regulatory system has to be both able to code for highly different levels of expression and to 
be very specific. 
The genome contains approximately 20,500 true protein-coding genes8, however their coding 
parts take only approximately a fraction of 1% of its entire length9. This does not mean that 
all of the rest is “junk”. Up to a fraction of 10-20% is likely to contain gene regulatory 
information based on multiple lines of evidence such as evolutionary conservation, regions 
associated to diseases or phenotypic traits, as well as direct evidence based on high-
throughput analyses10,11. 
Instructions about protein expression levels may sound uninteresting to a layperson, but as 
those regions also contain the blueprints of the entire animal, an understanding of the code or 
“language” of gene regulation would be the way to answer the ages old question; what 
separates mice from men?  
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1.2 REGULATION OF THE CHROMATIN STATE 
The entire human genome is composed of over three billion (>3,300,000,000) DNA base 
pairs. It is almost two meters long chain of atoms and yet it is composed of only 23 massive 
molecules known as the chromosomes. Remarkably, two copies of the genome are packed 
into the nucleus, an ellipsoid with a diameter of only approximately 10µm. This tight 
packaging leads to an extremely crowded environment. It has been estimated that the total 
concentration of macromolecules, DNA, RNA and proteins, is in the range of over 100-200 
mg/ml12, which is higher than the solubility limit of many of the individual proteins. 
Furthermore, this packaging needs to be carried out in a efficient manner; the genome must 
not get entangled and all of its functional regions need to be situated in appropriate locations 
of the nucleus to allow precisely controlled transcription of all required genes. Unless the cell 
is one of the types that have lost their ability to divide, such as certain neurons, the genome 
packaging must also be capable of ordered disassembly in order to replicate the genome13. 
Unlike transcriptional regulation in simple organisms such as bacteria, where a single 
transcription factor target site can regulate multiple genes, the regulation of transcription in 
multicellular organisms is very complex. In eukaryotic organisms the length of gene 
regulatory elements is typically from hundreds to thousands of bases and these regions 
contain target sites for tens of transcription factors. Furthermore very little of the eukaryotic 
DNA occurs in naked state, but most of it is packaged around histone proteins to form 
nucleosomes, which is the smallest unit of the functional genetic material called chromatin3. 
The chromatin state, the extent to which the DNA is packaged by binding to nuclear proteins, 
is used as a gene regulatory strategy in eukaryotes, as the degree of packaging makes these 
regions harder or more easily accessible by both TFs and the basal transcriptional machinery. 
The chromatin state is controlled on many levels all the way from individual nucleosomes to 
up to the organization of the entire nucleus14.  
Chromatin can be roughly classified into two different categories, inactive heterochromatin 
that is by far the more common type in human, and active euchromatin that is limited mainly 
to genes and regulatory elements that are active in that cell. “Silenced chromatin” does not 
necessarily mean that the associated genes are also silenced, as the silenced region can just as 
well be a negative regulatory element, whose silencing activates the gene it normally 
represses14,15. 
Both hetero- and euchromatin are associated with nucleosomes that are spaced by 10-70 
bases of free DNA, but the density of this packaging is different and both chromatin types 
bear their own distinctive epigenetic markings, which can be either covalent modifications of 
DNA by methylation of the cytosines located in the CpG dinucleotides, or through 
modification of the N-terminal regions, the “tails” of the histone proteins14,15.In 
heterochromatin, the nucleosomes are separated by only very short and evenly spaced gaps of 
DNA and the tails of the different nucleosomes contact each other through protein-protein 
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interactions leading into further wrapping of the entire thread to form a 30 nm thick 
chromatin fiber in which only very little of the DNA is exposed to the external environment. 
In contrast, in euchromatin the spacings between the DNA bound histones are much longer 
and of more variable length, resembling beads on a string rather than the thick fiber of the 
heterochromatin16.  
 Some genomic regions have the same chromatin state in essentially all types of cells. For 
example, genes that serve general housekeeping duties are in a euchromatic state in 
practically all cells. Regions that are in a heterochromatic state in all cell types are called 
constitutive heterochromatin, this is in contrast to facultative heterochromatin, whose state is 
different depending of the cell type. Constitutive heterochromatin includes structural regions 
such as telomeres, the “protective caps” located at the end of the chromosomes; centromeres, 
which are used to move and bind together chromosomes during mitosis as well as repetitive 
regions that are often derived from parasitic genomic elements. Facultatively heterochromatic 
regions on the other hand are packaged either into hetero- or euchromatin depending on the 
cell type and include regulatory and coding parts of genes. In general, the less differentiated 
cells have more euchromatin, which during differentiation gets locked up more and more into 
a heterochromatin state17. 
1.2.1 DNA CpG-methylation  
Around 90% of all CpG (C followed directly by G) dinucleotides are methylated in human 
cells. Besides CpG dinucleotides, methylated cytosines can occur also in different sequence 
contexts. Non-CpG methylation (most commonly CAG) exists in mammalian pluripotent 
stem cells of both embryonic and artificially induced varieties, but is lost when the cells 
differentiate. This is likely because the non-CpG methylation is not actively maintained with 
a specific enzyme like CpG methylation (see below)18. The methylated CpG dinucleotides are 
not distributed evenly in the genome; in general, heterochromatin is more methylated than 
euchromatin, and the degree of methylation also varies within these regions.  
CpG is methylated by DNA methyltransferase enzymes (DNMT:s) that either methylate the 
cytosines of the CpG residues de novo (DNMT3A, and DNMT3B), or function as a 
maintenance-methylase (DNMT1). The latter maintains CpG methylations by recognizing the 
positions where only one of the two cytosines on the sister strands is methylated, a situation 
that commonly occurs after DNA replication. The effect of CpG methylation depends on the 
context: methylation of regulatory DNA-regions has usually a silencing effect. Heavily 
methylated regions are packaged tightly into heterochromatin, where the internucleosomal 
regions are even more highly methylated than the parts that are wrapped around the core 
histones19. On the other hand, mCpGs occur also commonly in the gene bodies of active 
genes, which is thought either to serve as a way to suppress spurious initiation of transcription 
from within the genes, or to be simply a passive feature of the relatively open chromatin 
structure that makes it easier for the DNMT-enzymes to access their substrate20.  
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CpG methylation can be reversed passively as the replication cycles of the genome will 
initially generate unmethylated DNA, until methylation of the daughter strands by DNMT1. 
Active mechanisms on the other hand are based on a multi-stage process: in the first step, so 
called TET-enzymes catalyze the oxidation of the methyl group, first to hydroxymethyl, 
which can then be oxidized further to produce 5-formylcytosine and finally 5-
carboxylcytosine. In the second step, the entire oxidized methylcytosine base is removed by 
base excision repair. There is also some evidence for other cellular processes that could be 
used to reverse the methylations and restore the DNA base back to its original state, but so far 
their existence is controversial21.  
CpG methylation is used as a general mechanism in the regulation of the chromatin state and 
as a way to modify the transcription rates of genes, but it is also used in a few special cases 
such as in the inactivation of the entire second X-chromosome in female mammals, as well as 
in silencing of parasitic DNA such as endogenous retroviral elements22. Furthermore, there is 
at least a single relevant context, imprinting, where the mCpG based epigenetic modification 
states are even passed from one generation to the next. In imprinting, certain genomic regions 
are silenced if they were inherited either from the mother or the father. Imprinting has been 
estimated to affect expression of 200-1300 mouse genes (around 1-6.5%)23.  
The mCpG based silencing of gene regulatory elements is thought to be mediated primarily 
by proteins that have dedicated methyl-CpG binding domains (MBDs). MBDs bind to 
methylated CpGs regardless of the sequence context of the flanking regions and recruit 
proteins that modify histone tails or remodel the associated regions into heterochromatin 19. 
CpG methylation has also a direct effect on the binding of many sequence specific TFs. Many 
TFs can bind sequences that contain a CpG dinucleotide, and the methylation of these sites 
can affect the binding affinity of the TF, in most of the known cases this effect is negative, for 
example binding of certain TFs from the AP224-, bZIP25- and bHLH26 structural families has 
been shown to be inhibited by CpG methylation of their target sites. In some cases, TFs can 
however bind mCpG methylated sites better than the unmethylated variant or even recognize 
novel mCpG-sites that would not be bound in the absence of methylation27.  
1.2.2 Histone modification, assembly and remodeling 
Histones are multiprotein complexes composed of four to five types of protein subunits. The 
central ”core” part is functionally like a spool made of positively charged protein molecules 
that binds to the negatively charged DNA backbone leading to coiling of 147 bp of DNA 
around it. Core histones are composed of eight protein molecules, two copies each of the 
H2A, H2B, H3 and H4 subunits. Besides this octameric core, many nucleosomes, especially 
the ones located in heterochromatin, have an additional protein part known as the linker 
histone H1, located at the points where the DNA exits the core region. Cells express many 
variants of the five different types of histones, some of which have been shown to have 
important roles in gene regulation, e.g. the variant form of histone H2A, H2A.Z which occurs 
predominantly in the nucleosomes that flank the open regions of the genome and is thought to 
decrease the strength of the nucleosome-DNA interaction28. 
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Both DNA replication and transcription remove all histones from the DNA, after which they 
are loaded back into the DNA by histone chaperones15,29. Loading of the histones is likely to 
be carried out in two phases, where a tetramer composed of two H3 and two H4 subunits is 
loaded first, followed by loading of H2A-H2B heterodimers, and this happens without 
external energy sources30.  
 
Figure 1 | Nucleosome 
Figure shows the crystal structure of a nucleosome displayed as two different representations, as a cartoon (left) 
and a space filling model (right), the latter of which has been also turned by 90 degrees counter-clockwise. Four 
histone subunit proteins are marked with different colours (H2A, pink; H2B, orange; H3, violet; H4, cyan) and 
the commonly modified lysine residues have been marked as space-filling green representations in both of the 
views. Note the multiple modifiable positions on the tails of violet H3 and that they are located in the positions 
where the DNA enters and exits the nucleosome spool. The structure has been visualized using UCSC Chimera31 
from PDB structure 1KX532. 
1.2.2.1 Histone modification 
Multiple amino acid residues located on the N-terminal “tails” of the four core histone 
proteins can be modified through covalent addition of side groups. Different amino acid 
residues of the H3 and H4 proteins can be at least acetylated, methylated, phosphorylated, 
sumoylated or crotonylated14,29. In addition, the tail region of H3 can be cleaved off by a 
specific protease29 H2A and H2B proteins on the other hand are limited to ubiquitination of a 
single position. Some of the histone modifications, such as phosphorylation and acetylation 
can directly affect the interaction between the histone and the DNA, as they change the 
charge of the affected amino acid residues14. Different histone modifications can change the 
accessibility of the underlying DNA. Based on nuclease protection assays, the modifications 
can either decrease or extend the canonical nucleosome-contacted length of DNA from ~147 
bases to 106–164 nuclease protected bases33. A detailed analysis of all possible modifications 
is beyond the scope of this work and this introduction focuses instead on a few prominent 
examples.  
  7 
Acetylation of lysine residues can occur on multiple positions of the H3 and H4 proteins and 
all these modifications activate chromatin. Most of the enzymes catalyzing acetylation, the 
histone acetyl transferases (HATs), are promiscuous and can acetylate many different lysines 
of the histone tails. Addition of an acetyl group to a lysine residue neutralizes its positive 
charge and can thus have a relatively strong direct effect on the contacts between histone and 
the DNA backbone. Besides the direct effect to the histone-DNA interaction, these 
modifications function also as a way to recruit chromatin-modifying enzymes. The acetylated 
lysines can be recognized by protein folds known as the bromodomain and the plant 
homeodomain (PHD), which occur for example in several histone-remodeling enzymes15. 
Conversely, histone acetylation can be reversed by histone deacetylases (HDACs), which is 
usually connected to silencing of the genomic region. The connection of histone deacetylation 
to silencing is however not total. While promoters of active genes are often acetylated, the 
coding regions contain both acetylated and deacetylated histones, and it has been suggested 
that this is connected to elongation of the transcript in a dynamic fashion serving the same 
function as the CpG methylation of the gene bodies. Based on this theory the histones would 
be acetylated in front of the RNA polymerase to help the transcriptional elongation, after 
which they would be deacetylated again to inhibit sporadic initiation of the transcription from 
within the coding regions of the genes34. 
Histone methylation can occur on either lysine or arginine residues of H3 and H4, and this 
modification can have either activating or silencing effect depending on the amino acid 
residue that is modified within the histone tail. The most common activating methylations are 
mono-, di- and tri- methylations of lysine 4 of the histone 3 protein (H3K4Me[1,2,3]) and the 
most common silencing ones are the mono-, di- and tri- methylations of lysine 27 of histone 3 
(H3K27Me[1,2,3]). The distinct effects of different methylations are also mirrored by the 
enzymes that add or remove these groups, as in contrast to the promiscuous HATs and 
HDACs, the histone- methyltransferases and demethylases are position-specific. Histone 
methylations do not change the charge of the affected residues and thus have no direct effect 
on the interactions between the lysines and the DNA backbone. Their effect is instead 
dependent on proteins that recognize and bind to these modified positions. Different 
methylations can cause very specific effects, for example the trimethylation of lysine 36 of 
histone 3 (H3K36Me3) is used to specifically guide and promote DNA CpG methylation of 
nearby bases through the action of de novo methylases DNMT3[A,B]. At least ten different 
kinds of protein domains have been shown to be able to recognize specific methylated 
positions on the histones14. 
1.2.2.2 Histone remodeling 
Besides the passive histone loading processes facilitated by the histone chaperones, the core 
histones can be loaded, moved around or ejected actively from the DNA by many 
multiprotein complexes called chromatin remodelers that modify chromatin structure using 
ATP as their energy source. There are at least ten distinct remodeling-complexes in human, 
and the actual diversity is even higher because of multiple paralogues for many individual 
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subunits. Some of the chromatin remodelers are used mainly in activating processes, while 
others are specialized in silencing and they are recruited to their target regions either by 
recognition of modified histones or by direct action of sequence specific TFs. Nucleosomes 
can be repositioned by sliding them along the DNA-strand, a process which can both package 
the histones into tight and evenly spaced arrays or reverse the tight packaging. Some 
chromatin remodelers can also catalyze the replacement of constituents of the nucleosomes, 
reducing the octameric nucleosome to tetrameric or even ejecting the nucleosomes altogether 
from the DNA15,35. Histone modification, especially histone deacetylation, and chromatin 
remodeling are tightly connected to each other. For example, one of the remodeling 
complexes, the nucleosome remodeling and deacetylation complex (NuRD) contains an 
mCpG recognizing subunit that is connected with domains with histone deacetylase and 
histone remodeling activities and thus both of these silencing functions are performed 
simultaneously in an mCpG guided fashion34,35.  
1.2.2.3 Nucleosome positioning 
Conceptual separation of chromatin into only two kinds of states is a very rough 
generalization. Although heterochromatin is indeed often packaged into a very tight, almost 
crystalline state, euchromatin is more like a wide and heterogeneous continuum of more or 
less accessible states. Recent high throughput studies using mainly DNAseI hypersensitivity 
assays and ChIP-seq with anti-histone antibodies, have shown that the transcription rate is 
commonly regulated through dynamic competition between TFs and nucleosomes. It has 
been shown that the transcription cannot be initiated if a nucleosome is binding too closely to 
the TSS. Moreover, a suitably placed nucleosome at a distal regulatory element can inhibit 
contact formation with its target promoter36. Promoter core regions, the areas immediately 
adjacent to the TSS, are cleared of nucleosomes in active genes where the average 
nucleosome free area is 200bp long, with 80 and 120 bp distances between the TSS and the 
first up- and downstream flanking histones, respectively28,33. Positioning of the nucleosomes 
is affected by many different things, such as direct competition against DNA bound TFs, the 
presence of RNA polymerase II, CpG methylation, chromatin modifying/remodeling 
complexes and even by the inherent sequence specificity of the nucleosomes themselves (See 
below)36.  
Nucleosomes are not sequence specific in the same sense as TFs; they do not define 
continuous DNA sequences that could be described well using a motif representation. Instead 
their specificity is more about the local shape and deformability of the DNA and their 
specificity manifests as preference for certain dinucleotides in an approximately 10bp 
periodic pattern, as well as strong disfavoring of certain DNA sequences such as stretches of 
A or T nucleotides. Even though none of the individual DNA binding regions of the 
nucleosome footprint has a strong determining effect on its positioning, the sum of all 
individually weak positions over the entire 147 bases wide footprint of the nucleosome can 
yield strong net influence37. 
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1.2.2.4 Inducers of active (open) chromatin state 
Chromatin state activating TFs can function through many different mechanisms. Even 
though binding of essentially any TF will by itself compete against the binding of the 
histones, it is clear that in most cases the major effect is mediated by enzymes that are 
recruited by the TFs activation domains. These enzymes include mCpG demethylating TET-
enzymes21, histone modifiers such as histone acetyltransferases like p300/CBP, histone 
methyl-transferases (activating types, e.g. H3K4 specific methyl-transferases) or other 
chromatin remodelers that modify the chromatin towards the more open state5,35.  
Some of the activating TFs seem to be especially suited for binding to tightly packed 
heterochromatin, and these “pioneer factors” have been suggested to kickstart the activation 
of silent chromatin. Moreover, some pioneer factors have been suggested to not even require 
cofactors but to be sufficient to open compacted chromatin as their intrinsic property38. TFs 
belonging to the forkhead (FOX) structural class are for example thought to be particularly 
suited for these tasks: Their DBD is structurally highly similar to H1 linker histones39, and 
can, like H1, access the major groove of histone bound DNA that is facing the nucleoplasm 
rather than the core histones. Unlike the linker histones, FOX TFs however recognize specific 
sequences and if such a site is present at the nucleoplasm facing major groove of the DNA, 
the TF will bind to it, causing eviction of the histone. Some of the FOX TFs like FOXA1 also 
contains a specialized C-terminal domain that can bind to the core histone proteins of the 
nucleosomes40. Other TFs suggested to function as pioneer factors include other forkhead 
TFs, various GATA TFs38, and POU5F1, one of the Yamanaka factors. POU5F1 appears to 
be a particularly potent pioneer factor, as it functions in rebooting the cell all the way to 
pluripotent stem cells41. 
1.2.2.5 Inducers of silenced chromatin state 
TFs that silence gene regulatory regions recruit corepressor complexes that have an 
essentially antagonistic set of enzymatic affinities when compared to activator TFs. These 
include HDACs, certain histone methyltransferases (inactivating, e.g. H3K27 specific 
methylases) and different sets of chromatin remodeling ATPases.  
In early development, many lineage defining genes are silenced by the action of polycomb 
repressor complexes (PRC) that are recruited to their promoters by stemcell specific TFs, 
such as POU5F1 (which can function both as an activator and a repressor, depending on the 
DNA sequence and the presence of other TFs), SOX2 and NANOG. The first of the recruited 
PRC-complexes is PRC2, which mediates its silencing effect through H3K27 specific 
methyltransferase activity. In further steps the methylated H3K27 recruits the PRC1 complex, 
which mediates tighter packaging of the local chromatin42. During differentiation it is 
common (and in many cases this is PRC2 mediated) that the gene regulatory elements are 
neither fully silenced nor activated, but remain in a “poised” state, where chromatin is 
accessible and an inactive form of RNA polymerase II is loaded onto the promoter, but it is 
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kept inactive through H3K27Me3 and associated changes. Once the cell differentiates, a 
subset of these promoters get fully activated to guide cell differentiation34,42. 
Some of the TFs have specialized into an “all or nothing” type of silencing of genomic 
regions, particularly zinc finger proteins that contain SCAN and/or KRAB effector domains. 
A very large fraction of the analyzed TFs of this type have been shown to bind to different 
kinds of parasitic genomic sequences such as endogenous retroviral elements43, where they 
serve as a form of molecular immunity that is used during early development to silence these 
elements. The KRAB and SCAN effector domains recruit KAP1-protein, which in turn 
mediates silencing of the nearby genomic regions through further recruitment of chromatin 
modifying enzyme complexes, nucleosome remodeling and deacetylase (NuRD), SETDB1 
(histone methyltransferase) and heterochromatin protein 1 (HP1)44.  
1.2.3 Composition and types of gene regulatory elements 
The genomes of complex multicellular animals contain massive numbers of regulatory 
elements, in the scale of hundreds of thousands, making up to 10-20% of the total base 
content of the genome10. Based on systematic DNAse-seq analysis of 125 human cell and 
tissue types there could be close to two million gene regulatory elements45. 
Regulatory elements can be classified based on their location relative to target genes or by 
their typical roles. Transcription is started from the transcription start site (TSS), which is 
located from tens up to a couple of thousand bases (human average distance is 210) upstream 
of the coding sequence of the gene46. Regulatory regions around the TSS are called 
promoters. The promoters have typically two distinct regions; the promoter proximal region 
that is located from tens to a few hundred bases upstream of the TSS and contains binding 
sites for sequence specific TFs, and the promoter core-region that is located directly over the 
TSS and often contains some of the general promoter sequence elements, such as the initiator 
element (Inr) or the TATA-box that function as binding sites for general transcription factors 
(proteins that are used as components in either all or at least a large subset of transcription 
initiation events). A single gene has often multiple promoters, and the choice of which of 
them is used to regulate transcription varies between cell types47. Based on occurrence of 
DNAse I hypersensitive areas near TSS positions it has been estimated that there are between 
75,000 to 150,000 promoters that drive expression of the human genes45.  
In addition to promoters, there are several types of gene regulatory elements that are 
positioned further away from the TSS (distal elements) such as enhancers, silencers, and 
insulators. Distal elements are located typically around tens of thousands, but up to hundreds 
of thousands of bases either up- or downstream of the TSS of their target gene(s). Distal 
elements function by forming contacts with either promoters (most enhancers and a subset of 
silencers) or each other (insulators). These contacts are used to guide the folding and packing 
of chromatin, and in the case of promoter contacts, to also modulate the expression rates of 
the associated genes by guiding the assembly of the basal transcriptional machinery, a 
massive multi-protein complex called Pre-Initiation Complex (PIC)6). The nature of the 
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regulatory element is often context dependent, and the same element can function either as a 
silencer, enhancer or even insulator depending on the TFs that are bound to it. Even the 
distinction between promoter proximal regions and distal elements is a question of threshold 
of distance between promoter and the TF target sites rather than a genuine difference. 
Moreover, proximal promoters of a pair of genes have been shown to effectively function as 
each other’s enhancers48. 
Many of the regulatory elements do not fit the traditional classifications very well. A form of 
negative regulatory element can function effectively as a decoy to which an enhancer will 
bind instead of the target promoter. In blood cell development for instance, the expression of 
the gene KIT is suppressed by the TF GATA1, which guides its enhancer to contact a gene 
regulatory element downstream of the TSS instead of the KIT promoter49. Other kinds of 
indirect mechanisms could be for example based on two regulatory elements that would help 
to compress the span of chromatin between the actual enhancer-promoter pair, or on making 
a negatively functioning element by forming a bulky, sterically blocking loop adjacent to a 
promoter or enhancer50. 
Thus it is important to keep in mind that the classifications of the different kinds of regulatory 
elements are just rough generalizations made to facilitate their description using human 
language while their real character is often dependent on the cellular context. 
1.2.3.1 Enhancers 
An enhancer and the promoter that it modulates are connected to each other by looping and 
then folding and compacting out the intermediate region of the chromatin, and these two 
elements are usually located relatively close to each other. An bioinformatics study based on 
analyses of previously generated data from Chromatin Interaction Analysis by Paired-End 
Tag Sequencing (ChIA-PET) assay performed with RNA polymerase II antibody, estimated 
that the median distance of enhancer-promoter pairs was 15,000 bases in the two analyzed 
cell lines51,52. 
An enhancer often controls the promoter closest to it, but in many cases the connecting 
stretch of chromatin can span hundreds of thousands of bases and contain multiple other 
genes. In a few extreme instances enhancers have even been shown to drive expression from 
promoters that are located on different chromosomes. For example, each smell sensing 
neuron expresses only one out of hundreds of possible olfactory receptor genes encoded in its 
genome, and these receptor genes are scattered into tens of loci in almost all chromosomes53. 
Choice of the olfactory receptor that the cell will express appears to be a stochastic process in 
which the enhancer gets connected to a promoter of a single olfactory receptor gene 
regardless of its location in the genome. Nevertheless, the likelihood of getting connected to 
the enhancer is higher for those receptor genes that are located in close positions of the same 
chromosome54.  
Traditionally the active promoter of a gene was thought to be connected to only one enhancer 
at a time, based on recent high-throughput studies it however seems that exceptions to this 
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rule are common; multiple enhancers can be connected to the same promoter in as often as 
25% of cases. Many promoters can also be connected to the same enhancer 
simultaneously48,55. 
1.2.3.2 Silencers 
Classification of the silencers is often ambiguous, as the term is used to describe many kinds 
of different elements such as negative regulatory elements (NRE) and traditional silencers. 
NREs are individual target sites for repressive TFs that are located in the promoters and 
enhancers and function either by blocking a DNA binding site of an activator, or by otherwise 
hampering the assembly of the PIC components by e.g. blocking a necessary protein-protein 
interaction interface of a general TF. Traditional silencer elements on the other hand are 
dedicated regulatory elements that have multiple TF binding sites and function similarly to 
enhancers by forming a contact with their target promoter, which however does not lead to 
transcription, as the silencer lacks several of the key binding sites required for transcriptional 
activation. Other kinds of silencer regions and elements are used to bind repressor TFs that 
operate indirectly through further recruitment of co-effectors, HDACs or DNA 
methyltransferases leading to modification of the local chromatin towards a suppressed state. 
These kinds of silencers are used to repress entire regions of chromatin during cell 
differentiation5,6.  
1.2.3.3 Insulators 
Early findings showed that the effect of enhancers can be limited with gene regulatory 
elements known as insulators. These elements appear to inhibit the contact between 
enhancers and promoters, as shown experimentally by introduction of a new insulator 
element between the promoter and its enhancer56. From early on one of the main theories to 
explain the function of the insulators was that they are used to separate the genome into local 
domains. This has been now confirmed through chromatin conformation capture (3C) based 
high throughput experiments (Hi-C), which showed that the genome is organized into about 
megabase long locally folded regions called topologically associated domains (TADs). The 
TADs are visible in the Hi-C experiments as regions within which sequences contact each 
other much more commonly than they do in the outside lying regions, and thus are likely to 
represent chromatin that is packed into the same local structure. The beginning and the end of 
these regions are associated to each other even more commonly than the regions within, 
suggesting that the TAD is a loop of chromatin that is then folded further into a tight globule. 
Most of the enhancer–promoter interactions are limited to occur within TADs and their 
borders correlate well with both known insulator elements such as CTCF as well as the 
boundaries of the genome’s division into hetero- or euchromatin57,58. Further upgrades to 
chromatin conformation capture methods have shown that the megabase TADs can be 
subdivided into even smaller locally folded regions, many of which have enhancer-promoter 
pairs located at the points where the ends of the domain contact each other. When taking 
together both the megabase level of organization (insulator dependent) and the local level 
folding of the genome that is connected to the transcriptional regulation, the human genome 
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seems to be organized into median locally folded compartments of a median size of 185 
kilobases59.  
Unlike the enhancers and promoters that are composed of highly diverse sets of different TFs, 
the insulator elements contain a common sequence specific element that is recognized by the 
C2H2 zinc finger TF CTCF. This TF binds long and highly specific 
NGCGCCMYCTAGYGGTN target consensus sites that are, despite the length of the site, 
very common in the genome60. The prominent role of CTCF in genome organization is also 
highlighted by the fact that, similarly to the situation at the TSS, it can also position 
nucleosomes at defined spacings around its target sites33. The details of the mechanisms that 
tie the ends of TADs together are still unclear, but besides CTCF these contacts employ 
cohesin, which is a ring shaped multiprotein complex that can connect two nearby strands of 
chromatin by encircling them59. CpG methylation can be used as a way to mask the function 
of the insulator element by blocking the binding site of CTCF61. 
 
 
Figure 2 | CTCF binding specificity (From Study II) 
1.3 THE GENERAL TRANSCRIPTIONAL MACHINERY 
Transcription is initiated by the assembly of the Pre-Initiation Complex (PIC) that is 
composed of many general transcription factors (26 peptides on six complexes; TFIIA, 
TFIIB, TFIID, TFIIE, TFIIF and TFIIH, making altogether 1560 kD) and the RNA 
polymerase II (12 peptides, 515 kD). Experiments using isolated proteins have shown that 
these components of the PIC are sufficient to drive low level expression even in the absence 
of the mediator complex (composed of 21 peptides with a total molecular weight of ~1005 
kD), but mediator is required for more efficient transcription, where it channels the effects of 
the activating TFs bound on enhancer or proximal promoter. Furthermore, mediator is also 
required for the efficient transition from the PIC phase to the following steps, the pre-
elongation and then the actual elongation phase, where RNA polymerase II is released from 
its contacts with the rest of the PIC components in a controlled and stage-wise fashion. Many 
structures of the subunits of both PIC and mediator have been solved using x-ray 
crystallography and nuclear magnetic resonance (NMR), and recent research has even been 
able to generate low resolution cryo-electron microscopy based structures of partial PIC 
complexes, (see Figure 3)62,63. 
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Figure 3 | Partial structure of mediator and RNA-Polymerase II 
The figure shows a partial structure of the RNA-Polymerase II pre-initiation complex based on individual high 
resolution X-ray diffraction structures that were fitted to a low resolution cryo-electron microscopy based 
structure of the entire complex. The structure is shown from two angles, side and top, and has been visualized 
using UCSC Chimera31 using the data from PDB structure 4V1O63. 
The function of the mediator is to tether relevant enhancer element(s) to the promoter and 
through this to mediate the effects of the TFs, such as recruitment of the general transcription 
factors or chromatin modifying complexes to the PIC. TFs that are bound to the paired 
enhancer and promoter recognize different parts of the mediator and the composition of the 
mediator is varied to some extent depending on the cell type62,64. Based on various sources of 
new data, including our laboratory’s contributions, this tether is very commonly reinforced 
through action of cohesin, a very long oval-shaped protein complex that forms loop around 
the two strands of chromatin55,65,66. 
As initial stage of the PIC assembly, the TFIID, which is composed of TATA binding protein 
(TBP) and 10-12 other proteins called TAFs (TATA-associated factors), is recruited to the 
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promoter. Unlike most of the other elements of the PIC or mediator, the TFIID has inherent 
DNA and chromatin recognizing activity. It can bind to the TATA-element (consensus 
TATAAWR) with the TBP47, and a complex formed of two of its subunits TAFI and TAF2, 
which together recognize the second commonly occurring core promoter sequence, the 
initiator element (Inr, with YYANWYY consensus)67. TFIID components can also read 
epigenetic information, as the subunit TAF1 has two bromodomains that recognize acetylated 
positions on histone H468. Similarly, TAF3 has a plant homeodomain (PHD) that it uses to 
bind to H3K4me369. 
Next, is TFIIB binds upstream of TFIID, making contacts with both TFIID and the DNA. 
This assembly stage of the PIC is sufficient to bind RNA polymerase II and defines the start 
site for the transcription, but initiation will not occur until the remaining complexes TFIIE 
and TFIIH bind to the PIC (reviewed in62,70). 
It is unclear to which extent the PIC gets disassembled once elongation has begun and this 
probably varies on different promoters. It has been suggested that almost everything except 
for the TFIID is disassembled, or on the other extreme that even the mediator and the TFIID, 
TFIIE and TFIIH would be retained on their promoter associated positions to form a scaffold 
for the rapid reassembly of the PIC6. PIC is a very large multiprotein complex that is 
connected to DNA through many of its subunits and due to this its passive disassembly would 
be too slow for the regulatory needs of some promoters. One of the mechanisms used to 
facilitate the disassembly is through action of the ubiquitin system, which marks up some of 
the PIC components for proteasomal degradation. In other cases, the components can also be 
removed through action of nucleosome remodelers such as SWI/SNF complexes5. 
At many promoters, cells employ yet another layer of transcriptional control where 
transcription is paused after synthesis of the first 30 to 50 bases. Both the pausing and its 
reversal are controlled through interactions between the RNA polymerase II and additional 
proteins called elongation factors. Transcriptional pausing can be caused by the barrier 
presented by the first nucleosome, the phosphorylation stage of the C-terminal part of the 
active subunit of RNA polymerase II, or by tethering the RNA polymerase II to the promoter 
region by the action of DNA binding proteins. Sequence specific TFs are also commonly 
used in the control of theses stages. The MYC-MAX heterodimeric TF complex for instance 
promotes transcriptional elongation of many of its target promoters through recruitment of a 
kinase protein complex called p-TEFb that can phosphorylate the C-terminus of the RNA 
polymerase II and many other associated proteins71.  
1.4 GENERAL CHARACTERISTICS OF TFs 
Most TFs recognize quite small, on average about 11 bases long target sites. Each specific 
sequence of that length occurs approximately 700 times in the human genome. Furthermore, 
many of the positions within those target sites are not strictly defined, but have an average 
information content of 1.2 bits per base72 making a total of 13.2 bits. As the information 
content of an absolutely defined base is 2 bits, this means that an average TF defines only 6.6 
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full bases worth of information and thus the practical number of the binding sites is much 
larger than the 700 exact matches, in the order of tens to hundreds of thousands of sites72,73. 
TFs are essentially the DNA recognizing interface of gene regulation and thus their main 
function, besides DNA binding, is to bind to other proteins to recruit them to the regulatory 
regions of the genes. 
1.4.1.1 Regulation of TF activity 
TFs themselves are typically the targets of cellular signaling cascades and are regulated by 
different kind of mechanisms that are based for example on: 1) Expressing the relevant TFs 
when they are needed. 2) Activating or silencing those TFs that are already present in the cell. 
3) Controlling the amount of the TFs in the cells through targeted degradation.  
TFs can be in an inactive state due to many different reasons, for example the ATF6 and 
CREB3 type bZIP TFs are normally bound to the membrane of the endoplasmic reticulum 
and this membrane-binding domain has to be cleaved off to activate them74. As another 
example, all STAT TFs need to be activated by phosphorylation in order to translocate into 
the nucleus, multimerize and then bind DNA75 and most nuclear receptors need to bind to 
their target substrates in order to be able to bind DNA6. Many of those nuclear receptors, such 
as estrogen-, Vitamin-D- and progesterone- receptors are also controlled through active 
ubiquitin guided degradation systems to get rid of ligand bound TFs so that the cells can 
assay the concentrations of their target ligands accurately5.  
1.4.1.2 Effective copy numbers of TFs in cells 
TFs are expressed in relatively low numbers when compared to the general expression levels 
of proteins, for example a mass spectrometry based analysis of the human osteosarcoma cell 
line U2OS detected 36% of the estimated total of 20,000 proteins, and 23% were present in 
more than a 1000 copies. The total number of detected TFs was however only 20% of all 
approximately 1300 TFs, and only 7% were present in more than 1000 copies7. Recent 
genomics analyses suggest that the identity of a cell type is typically determined by 
expression of only a few master regulator TFs that are expressed in very high copy numbers, 
250,000-500,000 copies, which is in contrast to the rest of the around 200 TFs that are 
expressed in twenty- to fifty fold lesser numbers ~10,000 copies per cell7.  
1.4.1.3 TF effector domains 
In the simplest case, a TFs consists only of their DNA binding domain (DBD), such a 
minimal TF can either repress expression of an activator TF by simply competing for binding 
into the same site, or it can exert its function by cooperating with another TF through protein-
protein or DNA shape -mediated interactions. An example of such a minimal TF is BATF 
that is composed of only 125 amino acids, and functions through forming heterodimers with 
other bZIP TFs76.  
Most of the TFs however contain dedicated effector domains besides their DBDs, which are 
usually connected to the DBDs by flexible linker regions. Effector domains are often simple 
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protein–protein interaction interfaces that are used to recruit several kinds of other proteins 
such as: 1) Co-activators and co-repressors, which are typically fairly large protein complexes 
with chromatin- modifying and/or remodeling activities. 2) Components of the basal 
transcriptional machinery, such as general TFs of the PIC or mediator components5,77. 
Many of the extensively researched TFs have fairly promiscuous effector domains that can 
form contacts with multiple different interaction partners, for example the activation domain 
of E2F1 has been shown to make contacts with many general TFs of the PIC5,77.  
Effector domains of most TFs have been characterized only very superficially. Some effector 
domains contain many acidic residues (aspartate and glutamate. e.g. E2F1 and TP53), while 
others are glutamine- (POU2F1, POU2F2 and SP1) or proline-rich (TFAP2A and NFIC). The 
linker region that connects the effector domains to the DBD is usually very flexible and it is 
likely that such unstructured linker regions are required because the TFs and the various 
proteins recruited by them will need to be able to make contacts with each other on the three 
dimensional environment around the sterically blocking DNA. Based on NMR experiments, 
most of the analyzed effector domains appear to be relatively unstructured when occurring 
free in the solution phase and only gain folded shape when binding to their target proteins77.  
Some of the TF effector domains are ambivalent; they can function either as an activator or 
repressor depending of the context. In many cases a TFs role is dependent on additional 
factors such as availability of cofactor(s) and the presence of other bound to nearby sites. In 
some cases it depends on the site that the TF is bound to, functioning as repressor on some 
and as an activator on others. This is thought to be mediated through allosteric effects, where 
binding of the TF to different sequence motifs leads to divergent changes on their fold, which 
then affects the properties of their protein–protein interaction interface. Examples of this kind 
of TFs include POU1F1, NFKB1 and several TFs from the nuclear receptor family5,78. 
1.5 TF STRUCTURAL FAMILIES 
Evolution has developed sequence specific DNA binding domains in many independent 
instances and some of these basic protein folds diverged to subfamilies so long ago that their 
relatedness to one another is not reflected anymore in their DNA binding specificities. For 
example, the ETS, FOX, RFX and even the linker histones of H1 type are all based on the 
winged helix-turn helix protein fold, but since each of these proteins binds sites that are very 
distinct from each other, or, in the case of the linker histones, have no specificity at all, it is 
not reasonable to discuss them here in the same context. Thus even though the classification 
scheme used here is based on evolutionary relationships of the TFs, it uses the DNA 
recognition specificity rather than e.g. a strict amino-acid similarity threshold as the basis for 
their classification into families72,79. 
Interestingly, some of the TF families have expanded to large numbers of members while at 
least in one case, the nuclear respiratory factor, the structural family has only a single TF in 
human (NRF1)79,80 
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To complicate things further, some of the TFs, such as several members of the 
Homeodomain- PAX-, POU- and CUT-families, contain two different kinds of DBDs that are 
often used in different orientation and spacing combinations72,73.  
Name Nr. of TFs Interpro Id. Name Nr. of TFs Interpro Id. 
znfC2H2 745 IPR015880 SMAD 8 IPR013019 
Homeodom. 243 IPR001356 CUT 7 IPR003350 
bHLH 115 IPR011598 RFX 7 IPR003150 
bZIP 56 IPR004827 STAT 7 IPR013801 
HMG 54 IPR009071 DM 7 IPR001275 
FOX 49 IPR001766 CP2 6 IPR007604 
Nuc.Rec. 46 IPR001628 MADS 5 IPR002100 
ETS 27 IPR000418 HSF 5 IPR000232 
T-box 17 IPR001699 AP2 5 IPR013854 
POU 16 IPR000327 TEAD 4 IPR000818 
Gata 15 IPR000679 NFI 4 IPR020604 
E2F 11 IPR003316 RUNX 3 IPR013524 
RHD 10 IPR011539 p53 3 IPR011615 
PAX 9 IPR001523, GCM 2 IPR003902 
IRF 9 IPR001346 NRF 1 IPR019526 
SAND 9 IPR000770 Total 1505  
Table 1. Structural classes of TF DBDs in human 
Table shows the 31 main structural classes of DBDs present in human, showing also for each of the classes the 
number of TFs containing the DBD and its defining Interpro identifier. Interpro is a protein family and domain 
classification database of the European Bioinformatics Institute (EBI).  
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The number of DNA binding specificities that a structural family has evolved to recognize is 
also highly variable, and there is very high degeneracy within many of the TF structural 
classes, such as Homeodomain, bHLH, bZIP, Forkhead and ETS, meaning that many TFs 
within a class binds to highly similar sites72,73,81,82, while other classes, in particular the 
znfC2H2 TFs can recognize a much greater variety of different target sites43,72. The 
degenerate specificity of some TFs is explained by the fact that many of them are expressed 
in a cell type specific manner. Thus, the functional differences are not in the TF itself but in 
its regulatory context, the availability of chromatin and the entire ensemble of TFs that are 
expressed in the same cell type. This is however unlikely to be the only explanation for the 
large number of TFs with highly similar specificities, as they are also often expressed in the 
same cells or in cells that follow each other in the developmental lineage. A good example of 
this kind of transitional change in the expression of similar TFs are the regulatory programs 
driving the development of the organism through the anterior homeodomain type of TFs that 
recognise highly similar and simple YMATTA consensus sequences83,84. 
In the following chapters the focus will be on briefly describing the structural classes of 
human TFs. 
 
 
 
Figures 4a-t | “TF-family name”; “Name of the shown TF”; PDB: “Protein Data Bank identifier” 
General layout of the following figures 4a to 4t. The figure title gives the the name of the structural class, 
followed by the name of the representative TF shown and the protein data bank (PDB) identifier. Figure panels 
show the crystal- or NMR- structures for the TF shown as cartoon models from two angles and as a space-filling 
model. A PWM based logo for either the shown or a paralogous TF is also shown. All PWMs are derived from 
data from Article II, except for situations where there were no available HT-SELEX models for the indicated or 
paralogous TF, in which case the protein contacted part of the crystal structures DNA is shown instead. DNA is 
displayed with the same colors in all figures, while the protein color varies. All of the structures have been 
visualized using UCSC Chimera31. 
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1.5.1.1 znfC2H2 
C2H2 zinc fingers are the largest family of TFs with 745 predicted genes in human. This 
protein fold is very versatile. Apart from sequence specific DNA binding in many prominent 
TFs, these domains are also used to perform protein-protein, protein-RNA, protein single-
stranded DNA and even protein-lipid interactions85, thus it is very likely that some of the znf 
C2H2 proteins are in fact not TFs at all.  
The name of this protein family is derived from the protein fold, where the peptide chain is 
folded into a compact structure through coordination of a zinc ion by two cysteine and two 
histidine residues. Unlike with other typical TFs, these domains are used in a modular 
fashion. There are typically from few to tens of these domains in a given TF, and domains 
that are ordered into tightly packed arrays are most often the ones that mediate the protein-
DNA interaction. This modularity is required because an individual znf domain has only 
small affinity and can recognize only 3-4 bases of DNA86. 
 
 
Figure 4a | znf-C2H2; GLI2; PDB:2GLI 
GLI2 has 5 ZNF C2H2 domains, but only four are binding the DNA in this structure. 
Before the recent findings that showed that most of these TFs (znf-C2H2 proteins with 
KRAB, SCAN or BTB domains) are used to silence parasitic genomic elements22,43 they 
could have been described as gene regulation’s dark matter, as most of them did not have 
proved functions, and many even lacked evidence for their existence on protein level. 
Consistent with functions related to “molecular immunity”, this protein group has had one of 
the highest rates of evolution in animal kingdom and between mammalian species there are 
large differences in the znf-repertoires87.  
1.5.1.2 Homeodomains 
Homeodomain factors comprise the second largest family with approximately 243 TFs. 
Homeodomains are composed of 60 amino acids and fold into a compact helix-turn-helix 
type of protein structure with three α-helices, one of which is the recognition helix that can 
contact bases in the major groove. Besides the contacts made using the recognition helix, 
homeodomains also contact several backbone positions, and the N-terminal “tail” inserts 
commonly into the minor groove of the DNA. Many of the homeodomains have important 
developmental roles, for example the classical homeodomains, HOX[A/B/C/D][1-13] that are 
used to define the anterior-posterior axis of the animal bodies84.  
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The homeodomain class is large but recognizes relatively small number of specificities. For 
example, over half of them bind highly similar sites with YMATTA-consensus72,82. Most of 
the homeodomain TFs have only this one DBD, but in some cases it occurs in conjunction 
with one or more of DBDs from other classes. For example all TFs of the POU and CUT 
types have a homeodomain in addition to the DBDs that have given these proteins their 
names84.  
 
 
Figure 4b | Homeodomain; PDX1; PDB:2H1K 
Besides the canonical YMATTA binding homeodomains there are several subgroups of 
homeodomains that recognize other specificities, for example, the posterior homeodomains, 
HOX9-HOX13 recognize a NNNTAAAA-type of sequence, PITX-class recognizes 
GGATTA and NK-class homeodomains recognize CACTTA consensus82. 
A special subfamily of the Homeodomains are the TALE factors, which is an ancient 
subgroup that existed even before the divergence of the three major kingdoms of multicellular 
life, the plants, fungi and animals84,88. This class recognizes sites that are very different from 
those bound by other homeodomains and there are four distinct types of them: MEIS 
(TGACAG), PBX (ATCA), IRX (ACAT) and MKX (TACA)89. TFs of this group are well 
known to bind cooperatively with each other or together with regular homeodomain 
proteins90-92.
1.5.1.3 Basic helix-loop-helix (bHLH) 
bHLH is the third largest group of TFs with 115 TFs in human. As the name suggests, the 
bHLH protein domain is composed of two alpha helices that are connected to each other by a 
peptide loop. The shorter N-terminal helix inserts into the major groove of the DNA and 
makes the base-specific contacts, while the loop region adds to the binding by forming 
contacts with the DNA backbone. The C-terminal helix is used as a protein-protein 
interaction interface for contacting other bHLH proteins. DNA recognition of these TFs is in 
all known cases based on homo- or heterodimerization with other members of the same 
group. bHLH family has many prominent members such as MAX and MYC, which function 
in the control of the cell cycle, as well as CLOCK, which functions in the control of the 
circadian rhythm of the cells93. 
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Figure 4c | bHLH; MAX; PDB:1AN2 
The dimeric nature of these TFs is mirrored by the sites they recognize, which tend to have a 
fully or partially symmetric six bases long core sequence. While the most common binding 
specificity of a half-site is CAC, certain members of the family have evolved to recognize 
other half sites such as CAT, CAG or CGC. Besides the core sequences, some bHLH TFs 
have evolved additional specificity also for the bases that flank the core sequence93.  
1.5.1.4 Basic leucine zipper (bZIP) 
bZIP is the fourth largest TF family with 56 TFs. As with the HLH proteins, most of these 
TFs need to bind as homo- or heterodimeric pairs with other members of the same structural 
class in order to bind the DNA. Exceptions from this rule are the members of the MAF-
subfamily, which can also bind as monomers94. The bZIP fold is arguably the simplest DNA 
binding domain, as it is composed of a single alpha helix that performs both the DNA-
binding and dimerization functions. Each bZIP TF has preferences for forming pairs with 
certain partners and these can be predicted based on the amino acid sequences of the leucine 
zipper regions95. The pairing preferences of the leucine zipper regions have also been 
determined experimentally and the results are mostly in good agreement with the 
predictions96. 
 
Figure 4d | bZIP; CEBPA; PDB:1NWQ 
bZIP proteins have evolved a wider range of target specificities than the bHLH factors, and 
based on the half-sites that they recognize these TFs can be divided into several subclasses: 
CRE (ATGAC); CREB3 (RTGCCAC); CEBP (RTTGC) (See Fig. above); MAF (TGCTGA) 
and TEF (RTTAC). 
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1.5.1.5 Forkhead 
Forkhead box (FOX) is a fairly large structural class with 49 TFs. Interestingly, the structure 
of these TFs, a winged helix-turn-helix protein fold, is similar to the H1 linker histones 
suggesting that these proteins share a common origin. This similarity is also reflected in the 
function of these TFs, as like the linker histones, many of these TFs can bind to DNA that is 
packed into a nucleosome 38,40. Many FOX TFs function in development and consistently the 
knock-out mouse models die at embryonic stage or just after the birth97. FOX TFs can be 
controlled through an impressive number of post-translational modifications, as an example, 
FOXO1 has been shown to be able to be phosphorylated on six serines by several different 
kinases and is also acetylated at two lysine positions by p300/CBP, enzymes that are better 
known as histone acetyltransferases98. 
 
 
Figure 4e | Forkhead; FOXO1; PDB:3CO6 
The canonical recognition site of the forkheads has an RTMAAYA-consensus, but these TFs 
have also evolved to bind multiple secondary target sequences such as: GACGC99,100; 
ACGGACACAAT and TTTCCCCACAC (Study II.72). 
1.5.1.6 Nuclear receptors 
There are 46 nuclear receptor TFs in human and this class is one of the most extensively 
studied TF families due to the clinical relevance of some of its members in e.g. breast and 
prostate cancers. Almost all of the nuclear receptors binds the DNA as homo- and 
heterodimeric complexes, although some members are also capable of binding to monomeric 
targets. Similar to znfC2H2 TFs, the protein fold of the nuclear receptors is also dependent on 
zinc ions, but is structurally very different101.  
 
 
Figure 4f | Nuclear receptor; RARA:RXRA; PDB:1DSZ 
The PWM is for RXRA homodimer binding the same spacing. 
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Nuclear receptors have evolved to recognize several types of sites with the following target 
consensus sequences recognized by the individual proteins: RGGTCA, which is the most 
common site recognized for example by estrogen receptor (ESR1) and retinoic acid receptors 
(RAR[A,B,G]); TCAAGGTCA, which is bound by the three estrogen receptor related TFs 
(ESRR); AAAGGTCA, which is bound by the NR4 subfamily; RRGWACA, which is 
recognized by the three members of the NR3 subfamily, one of which is the androgen 
receptor; RGTCCA which is bound by the two HNF4 TFs; AAGTCA, which is bound by 
NR2E1 and RRGTTCA, which is bound by the vitamin-D receptor. Besides their primary 
specificities, nuclear receptors have also diverged in terms of orientation and spacing 
preferences between their dimeric target sites, for example, while ESR and RAR TFs 
recognize the same monomeric consensus, the target sites are in different orientations; while 
ESR TFs bind a tail-to-tail orientation of the sites (NRGGTCANNNTGACCYN), the RAR 
binds to them in a direct repeat orientation (RGGTCAAAAGGTCA)101(Study II72). 
1.5.1.7 ETS 
There are 27 ETS TFs in human, and the family is structurally related to FOXes as they also 
recognize the DNA with a winged helix-turn-helix type of domain. Many of the ETS TFs 
have prominent roles in basal cellular functions, their target sites occur commonly on 
promoter regions near the TSS, and many of them are connected to particular forms of 
cancers102. 
 
Figure 4g | ETS; ELK1; PDB:1DUX 
ETS TF:s can be divided into four subclasses based on their DNA binding-specificity: 
ACCGGAAGN (Class I), ACCCGGAAGTN (Class II), AAAGVGGAAGTN (Class III) and 
ACCCGGATNN (Class IV)81. Besides binding as monomers, many ETS TFs can also bind 
as homo- or heterodimeric complexes. For example, ETS1 can bind DNA as homodimeric 
complex103,104, and ETS TFs have been found to form heterodimeric complexes with partner-
TFs from e.g. the FOX105, RUNX106 and PAX- families107. 
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1.5.1.8 HMG 
There are 54 High mobility group (HMG) TFs that can be divided into three categories, two 
of which, the SOX (20 TFs) and TCF7-like (4 TFs) types can bind DNA in a sequence 
specific manner, while based on both the earlier evidence and our HT-SELEX experiments, 
the remaining 30 HMG proteins either do not bind DNA or bind it in a non-specific manner, 
and thus are unlikely to be actual TFs. The most famous TF of the SOX family is the Y-
chromosome located SRY, the main sex determining gene in the mammals108.  
 
 
Figure 4h | top HMG-SOX; SOX17; PDB:3F27 | bottom HMG-TCF7; LEF1; PDB:2LEF  
Unlike most of the other TFs, the majority of the contacts made by the HMG DBD target the 
minor groove of the DNA. Binding of the HMG typically causes very large effects to DNA 
shape. The SOX subgroup of the HMG TFs binds variant sequences of an AACAAT-
consensus, while the four TCF7-like TFs bind a highly distinct AAAGATCAAAGGRWW 
consensus108.  
1.5.1.9 T-box 
The T-box family of TFs has 17 members, many of which have been shown to function in 
extra-embryonic tissues such as placenta, in early development during mesoderm formation 
and also in later developmental contexts such as tissue morphogenesis. The developmental 
roles of T-box TFs are highlighted by the fact that at least ten of the T-box TFs cause 
embryonic or neonatal death in knockout mice, and many of them are connected to different 
developmental disorders109. The DBD of T-box factors is large and bulky, offering broad 
surfaces for protein-protein interaction, and it contacts both major- and minor grooves of the 
DNA. The recognition mechanism is however mostly indirect, as the DBD contacts the bases 
on the major groove with only a single hydrogen bond and from the minor groove side by 
phenylalanines that insert to minor groove of the DNA, while the rest of the contacts target 
the backbone positions of the DNA110.  
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Figure 4i | T-box; TBX3; PDB:1H6F 
PWM is for paralog “T” that binds the same spacing as TBX3. 
All T-box TFs recognize very similar individual target sites with AGGTGTGA-consensus 
and they can bind this site both as monomers and homodimers. Homodimeric binding 
properties are different depending of the T-box paralog, at least three of the clawed frog T-
box TFs have been shown to have preference for different spacing and orientation 
configurations111. In Study II the same was observed for many human T-box TFs72.  
1.5.1.10 POU 
There are 16 TFs with a POU domain, and as described in the homeodomain chapter, all of 
the POU TFs contain also a homeodomain. The two protein domains are connected to each 
other via flexible linker regions that give these TFs the ability to recognize a large sequence 
space by allowing the two domains to connect to half-sites that are in different spacing and 
orientation combinations112. 
 
 
Figure 4j | POU; POU2F1; PDB:1OCT 
Most POU TFs can recognize the canonical TATGCAAAT target specificity, besides which 
they can also recognize similar sites where there is a longer distance between the target sites 
of the POU-specific- and homeodomains and additionally they can also recognize target sites 
as homodimeric complexes. Each POU TF can typically recognize a couple of different kinds 
of target sites. The preference that a POU-TF has for certain types of sites is at least to some 
extent determined by the length and sequence of the linker region that ties the two domains 
together, for example in the POU5F1 crystal structure, part of its linker is folded into an 
alpha-helix113, while in POU2F1 the linker is fully unstructured114.  
POU TFs are also known to make heterodimeric complexes with several different partners. 
Many cooperative pairs are formed between different combinations of POU and SOX TFs 
and depending on the pair they recognize, differently spaced POU:SOX composite motifs115. 
Interestingly the ubiquitously expressed POU2F1 has been also hijacked by Adeno- and 
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Herpes simplex- viruses where it heterodimerizes with viral proteins to control expression of 
the viral genes112. 
1.5.1.11 GATA 
A GATA domain is found in 15 proteins, and at least six of them (GATA[1-6]) are proven 
sequence specific TFs. Similarly to FOX TFs, the GATA-family members can function as 
pioneer factors that can bind to their target sites even when the sequences that contain the 
sites are loaded with nucleosomes38. 
 
Figure 4k | GATA; GATA1; PDB:1GAT 
The PWM is for the paralog GATA3, and the structure has only the N-terminal GATA-domain. 
GATA[1-6] TFs have two zinc coordinated DBDs that are connected to each other by a 
flexible linker sequence, the C-terminal of which binds to the canonical GATAA-target site 
in DNA, whereas the N-terminal domain binds to GATC-sequences if present in composite 
sites116. Alternatively, the N-terminal DBD can serve as a protein-protein interaction interface 
with its binding partner ZFPM1 (also known as “Friend of Gata”(FOG1))49.  
1.5.1.12 E2F 
There are 11 TFs with E2F domains that can be divided into two subclasses, E2F and DP 
domains. Six of the TFs, (E2F[1-6]) contain just an E2F domain, three (TFDP[1-3]) contain 
just a DP domain and two of them (E2F7 and E2F8) contain two E2F-like domains117.  
 
 
 
Figure 4i | E2F; E2F4(red): TFDP1(orange); PDB:1CF7 
No E2F proteins were tested as heterodimers in our HT-SELEX experiments, so the sequence in the crystal 
structure is shown instead. 
E2F[1-6] TFs bind DNA as heterodimers together with the TFDP[1-3], but it is still 
somewhat unclear which DNA-sequences are recognized by these complexes. For example, 
many older studies such as a SELEX study of multiple combinations of E2F and DP TFs118 
and a study analyzing E2F7117, suggest divergence of the specificities of E2F-DP complexes. 
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However the new data, such as in vivo ChIP-seq experiment derived motifs for E2F[1,4,6,7] 
in the Homer database119 and our HT-SELEX data for E2F[7,8], show that all of these TFs 
prefer very similar TTTCCCGCCAAA-like consensus. This issue still merits further 
research, as we have not for example tested the heterodimeric E2F combinations at all. 
1.5.1.13 RHD 
The Rell homology domain (RHD) class has 10 TFs that can be divided into two further 
branches, the NFκB and NFAT subfamilies with 5 members in both of them.  
 
 
Figure 4j | RHD; NFATC2; PDB:1P7H 
Members of the NFκB subfamily bind DNA as homo- or heterodimers with other members 
of the group recognizing a GGGGAWTCCCC consensus, while the NFAT TFs recognize a 
ARYGGAAANW consensus both as in mono- and homodimeric configurations120. 
1.5.1.14 Paired box (PAX) 
There are 9 TFs with a PAX domain, four of which, PAX[3,4,6,7], contain also a functional 
homeodomain (IPR001356). The PAX domain is composed of two folded domains that are 
connected by a tethering region, but unlike in many other TFs with this type of layout the 
tethering region is an active participant in the DNA-binding which inserts fully into the minor 
groove of DNA121. 
 
 
Figure 4k | PAX; PAX6; PDB:6PAX 
In SELEX experiments, the PAX TFs that contain only their eponymous domain 
(PAX[1,2,5]) bound to a GTCACGCWTSRNTG consensus, while the PAX TFs that contain 
also the homeodomain can bind to more variable sites. PAX6 binds a similar site, except for a 
putatively homeodomain derived TTT-sequence instead of the GT (PWM is shown in the 
figure above, although the structure contains only the PAX domain of the TF). The HT-
SELEX experiments performed using PAX[3,4,7] bound only homeodomain-type sequences 
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(TAATYGATTA for PAX[3,7] and general YMATTA for PAX4). Since the data is based on 
proteins expressed in human kidney derived cells this could for example reflect their post-
translational modification state. 
1.5.1.15 IRF 
The family of Interferon regulatory factors (IRF) has 9 members in human. As the name 
implies, these TFs are strongly connected to interferon mediated antiviral responses of the 
cells, but they are also used in other mostly immunity related gene regulatory contexts122. 
 
 
 
Figure 4l | IRF; IRF1; PDB:1IF1 
The protein has been crystallized with a DNA hairpin; the PWM is for the paralog IRF5. 
IRF TFs bind genomic target sites with often multiple copies of GAAANN consensus 
sequences. In the HT-SELEX we observed that the binding consensus was typically 
ACCGAAACYA, although some of the paralogs can also recognize secondary sites where 
the CCG sequence is replaced by GTG122. The strong tendency to form multimers was 
evident in our experiments performed in Study II. Based on the available crystal structures, 
the cooperativity of the multimeric target site binding IRF DBDs is mostly gained using close 
DNA allostery rather than through usage of protein-protein interactions, as in these structures 
there is little if any contact between the TFs123-125. 
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1.5.1.16 SMAD 
In human, there are 8 genes with a SMAD domain, the name of which is derived from the C. 
elegans protein SMA and the Drosophila protein “Mothers against decapentaplegic” 
(MAD)126. The structure of SMAD3 has been solved using X-ray crystallography, and as 
with the multimeric IRF structures there is very little interaction between the DBDs, 
suggesting that the cooperativity is gained mostly through DNA allosteric mechanisms127. 
 
 
Figure 4m | SMAD; SMAD3; PDB:1OZJ 
It has been suggested that SMAD TFs bind usually as heterodimeric complexes with other 
SMADs, in particular with the so called common mediator SMAD, SMAD4126. 
1.5.1.17 CUT 
There are 7 CUT domain TFs and similarly to POU-domains this domain is always connected 
to a homeodomain. POU TFs can be divided into at least two clear subclasses of sequence 
specific TFs; ONECUT[1,2,3] TFs contain only one of both CUT- and Homeodomains, 
while the other type CUX[1,2], has three CUT-domains, the most C-terminal of which is 
directly adjacent to the single homeodomain, just as it is in the ONECUT TFs. 
 
 
Figure 4n | CUT; ONECUT1; PDB:2D5V 
Based on the X-ray structure of ONECUT1, the two DBDs of the CUT TFs are located on 
opposite sides of the DNA when binding to their target site128. Unlike with POU-domains that 
can bind several spacing configurations of their two sites, the two DBDs are always located 
within fixed distance from each other in the overlapping composite motif. 
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1.5.1.18 RFX 
The RFX-family has 7 members in human, and as FOX and ETS TFs, its DBD is based on a 
winged helix-turn-helix fold. However, RFXs have evolved a different strategy for binding 
the DNA and recognizes different sequences129.  
 
 
Figure 4o | RFX ;RFX1; PDB:1DP7 
PWM is for the paralog RFX2. 
RFX DBDs can bind DNA as monomers or homodimers73,130. The site bound most strongly 
is GTTGCCATGGCAAC, but based on both earlier SELEX-experiments130 and our own 
findings from all three studies, these proteins can also recognize other binding configurations, 
the most relevant of which are the one and two bases shorter spacing variants of the same 
palindromic configuration. The structure of the RFX binding to its canonical palindromic 
target site has been solved using X-ray crystallography. In this structure two copies of RFX 
bind to opposite sides of the DNA without contacts between the DBDs, forming effectively a 
DNA-hamburger. This suggests that the TF uses a close DNA allostery based mechanism 
(see page 37 ) as basis for its recognition of the dimeric target sites129. 
1.5.1.19 STAT 
The STAT family has 7 members. All STAT-TFs need to be activated by phosphorylation of 
certain tyrosine residues in order to be transported into the nucleus from their general 
cytoplasmic locations and to bind to DNA. STAT-TFs are used by cells in interferon 
signaling131. 
 
Figure 4p | STAT; STAT1; PDB:1BF5 
There are no HT-SELEX models for any STAT TFs, so instead the TF contacted sequence in the crystal is 
shown. 
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All STAT TFs recognize very similar individual target sites TTC[2-4N]GAA that are bound 
as homodimeric configurations of the TFs, where most of the family members prefer either 
3N (at least STAT[1,2A,2B]) or 4N (STAT6)132. Based on the crystal structure of STAT1, the 
STATs are also capable of binding DNA as monomers. The STAT domain is massive when 
compared to general DBDs133.  
1.5.1.20 MADS 
MADS is an ancient TF-family with members occurring in species from all three kingdoms 
of life. It is a very prominent family in plants but relatively small in vertebrates with just five 
TFs134.  
 
Figure 4q | MADS; SRF; PDB:1SRS 
Besides the HMG TFs, this is the second class of TFs that contacts mostly the minor groove 
of the DNA instead of the major groove, and similarly to HMG-TFs this is also accompanied 
by a large shift in the shape of the DNA135. 
1.5.1.21 RUNX 
The RUNX family is composed of only 3 TFs. One of the TFs of this class, RUNX1, is 
commonly connected to different types of leukemia, where a chromosomal fragment gets 
fused to a specific locations on other chromosomes leading to a fusion proteins that combine 
the DBD of the RUNX1 to the activator domains of other proteins. Over twenty of these 
kinds of gene fusions have been found, the six of which have occurred on tens to thousands 
of instances136. All RUNX TFs are connected to regulation of the cell cycle of distinct types 
of cells, in which they can either promote or inhibit cell division depending on either their 
post-translational modification state (acetylation or phosphorylation) or the cell type. Due to 
these roles, their silencing or activation is commonly observed in different kinds of 
cancers137. 
 
Figure 4r | RUNX; RUNX1; PDB:1HJC 
PWM is for paralog RUNX2. 
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RUNX TFs bind sites with DNA with a short WAACCRCAA consensus sequence that can 
occur either as a individually or as a direct repeat that is bound by homodimer. Based on the 
protein structure, the footprints of these TFs are relatively small. RUNX TFs function as 
heterodimeric complexes with an interaction partner called CBFB. RUNX and CBFB interact 
through a large protein-protein interaction interface, but this is unlikely to affect the 
specificity as the RUNX-CBFB interface is located on the opposite site of the RUNX 
domain, and CBFB itself does not interact with DNA138. RUNX1 has been also shown to 
bind DNA cooperatively with ETS1 using close DNA-allostery (see page 37) as the 
cooperativity mechanism106. 
1.5.1.22 p53 
This class contains only 3 similar TFs, but it is one of the most well known because one of 
the TFs, TP53, is connected to a wide variety of cancers. Typically, this TF gets either 
silenced or its coding sequence is lost when cells undergo malignant transformation139,140. 
 
 
Figure 4s | p53; TP53; PDB:3F27 
Configuration of the DBD is trimeric in the structure, while in reality the TP53 binds DNA as a quadrimeric 
complex. 
All p53 TFs have a dedicated protein-protein interaction interface contained in a specific 
domain that causes them to form quadrimers even when occurring in free solution phase, 
besides this they have also a dimerization interface located in the DBD. Consistently with the 
layout of their multimerization interfaces, they bind DNA as 2+2 configurations recognizing 
duplexes of sites with RRCATGYY sequences with highest affinity for combination where 
the duplexes are separated by a 2bp spacer141. 
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1.5.1.23 GCM 
There are two GCM TFs in human. Both are connected to neural function, and the name of 
the class “Glial cells missing” is derived from this. Similar to C2H2 zinc fingers and nuclear 
receptors, this TF is also folded around coordinated zinc ions, but this is likely to be a 
consequence of convergent evolution, as the fold is very different from any other zinc finger 
domain TFs. GCM proteins are conserved broadly in metazoans, existing both in Drosophila 
and mammals142,143. 
 
Figure 4t | GCM; GCM1; PDB:1ODH 
GCM factors recognize a distinct NATGCGGGTAC consensus with a long interface to the 
major groove of the DNA but with no contacts to the minor groove positions or the 
backbone143. 
1.5.1.24  TFs families with unknown structures 
The structures of DNA bound complexes have not been solved for the following TF families: 
Most of the heat shock factors (HSF, 5 TFs) have been suggested to bind DNA as trimers, 
although based on our findings two of them, the HSFX and HSFY, bind instead as dimers; 
TEAD (4TFs); NFI (4 TFs); AP2 (5 TFs); SAND (9 putative TFs) at least two of which, 
GMEB[1,2] bind DNA in a sequence specific manner based on HT-SELEX; CP2 (6 TFs); 
DM (7 TFs); and finally the nuclear respiratory factor NRF (1 TF). The single TF in the 
NRF-family occurs commonly in the promoter regions of genes, and due to this its target 
PWM is commonly found when motif detection is performed to ChIP-seq data. 
 
 
Figure 5 | PWMs for 8 TF families with unknown DBD structures 
Logos for representative members of the described TF-families are shown. The logo indicated with an asterisk 
describes the specificity of Drosophila melanogaster TF (Study III), while the rest of the logos are for human 
TFs (Study II). 
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1.6 GENERAL ATTRIBUTES OF TF – DNA INTERACTIONS  
1.6.1 Specific and nonspecific affinity and TF target site search process 
Typical mammalian transcription factors have a large number of potential target sites that are 
scattered throughout the vastness of the genome, yet the cells have to respond rapidly to 
external and internal signals and thus the search process for target sites must be fast. There 
are multiple mechanisms that have been shown to be used in this process. As seen in the 
previous chapters, most of the regulatorily irrelevant sequences are made inaccessible for 
most of the TFs by wrapping them tightly into heterochromatin form. This essentially 
decreases the ratio of target site containing sequences to total genomic DNA and could 
facilitate the TF search process144. The search speed varies for different TFs, which has been 
demonstrated in fluorescence recovery after photobleaching experiments (FRAP), where the 
TFs that can interact with nucleosomal DNA, such as the FOXA1 pioneer factor, exhibit the 
slowest mobilities in the nucleus145. 
The simplest assumption, namely that the target site search process is based on diffusion 
followed by readout of the encountered DNA would be too slow for the cells’ needs based on 
modelling of the nuclear conditions, even when taking only accessible DNA into account. 
The way the transcription factors solve this issue is to have a low nonspecific affinity to any 
DNA sequence in addition to the much higher affinity for their sequence specific target sites 
and these nonspecific contacts are employed by the TF as a way to scan the DNA sequences 
by sliding along it. This nonspecific affinity, typically achieved through contacts with the 
DNA backbone, is usually thousand times weaker (micromolar range) than the specific 
affinity (nanomolar range), but it is still a relatively strong interaction. In practice, the search 
process is probably a mixture of free diffusion within the nucleus that is then followed by 
episodes of two-dimensional search, the length of which is limited by DNA accessibility146. 
Advances in fluorescence microscopy based methods have made it possible to detect and 
analyse the TF-DNA binding of single molecules either in living bacteria147,148, on in vitro 
arrays of single molecules149 and even in living mammalian cells150. 
These analyses have shown for example that a specific transcription factor will stick to its 
specific target sites for a few minutes, while the non-specific affinity is very transient as the 
proteins are essentially scanning the DNA. The methods have also shown that for bacterial 
LacI, the average sliding distance observed in the two dimensional search process is 45 +/-1 
bases. The sliding nature of the search process means also that the local chromatin 
environment has influence on the association rate, as any other protein that is situated within 
the sliding distance of the target site will function as a roadblock. The equilibrium state of the 
binding process is however not changed as both the association and the dissociation are 
affected to similar extent148. New evidence points towards the view that the TFs often do not 
recognize their target sites in a single attempt, but that it is a more of a dynamic trial and error 
type of process, where the TF is likely to slide over its target site on many of their encounters. 
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It appears that the evolution has compromised in the trade-off between fast search process 
and the probability that the TF will attach to its target site148,150. 
1.6.2 Mechanisms of sequence specific DNA recognition 
Even though there are over twenty clearly distinct structural classes of DBDs, most of them 
have convergently evolved similar mechanisms to bind the DNA and also to recognize 
specific sequences in it. The phosphate groups located in the backbone of the DNA make it 
negatively charged, and thus positively charged amino acids (arginine, histidine and lysine), 
have affinity towards it. Moreover, the DNA backbone offers many options for formation of 
hydrogen bonds with both the phosphate and the sugar groups151.  
1.6.2.1 Direct readout of bases 
“Direct readout” refers to mechanisms where the amino-acid residues of the proteins are 
forming direct and base specific contacts with the DNA bases through hydrogen bonds and 
hydrophobic interactions. Each of the base pairs have distinct combinations of hydrogen bond 
donors and acceptors in the major groove of the DNA, which can be contacted by suitably 
positioned amino-acid residues of a TF. Thymines and methylated cytosines have also a 
hydrophobic patch that can be contacted by hydrophobic amino-acid residues or by nonpolar 
parts of an otherwise polar amino acid. The minor groove on the other hand offers a much 
more limited selection of groups for recognition that is practically limited to distinguishing 
A:T or T:A basepairs from C:G or G:C basepairs152. 
1.6.2.2 Indirect readout through DNA shape 
 Indirect readout refers to the ways nature has come up with alternative strategies to 
circumvent the limitations of the directly recognisable positions. The shape of the DNA is 
dependent on its base content and the most relevant way to view this property is through 
analysis of the adjacent dinucleotides. In regular DNA, there are 16 possible dinucleotides 
and each of them has a different shape due to differences in the stacking interactions between 
the adjacent base pairs and the interbase hydrogen bond formation in the cases of ApA, ApT 
and CpG dinucleotides153,154. The sequence also affects the deformability of the DNA, i.e. the 
range of the shapes that it can accommodate when under strain. Strain can be caused by being 
bound by proteins such as TFs or histones or by topological means, in essence by being 
under- or overwound by DNA- or RNA polymerases or enzymes known as topoisomerases. 
A common way of TFs to recognize local DNA shape is insertion of an arginine residue into 
a narrowed minor groove or making backbone contacts that reach over the minor- or major 
grooves. Local shape of the DNA can even be interrupted to a level where the DNA melts 
locally, meaning that the hydrogen bonds between the paired bases are pulled apart, and base 
positions can get turned out of the base stacking interaction152,155.  
1.6.3 Interactions between DNA-bound TFs 
It has long been suggested that the main difference between real functional motifs and 
randomly occurring target sites is that the functional sites are localized among other TF target 
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sites on regions that show evolutionary conservation. This is well supported by systematic 
chromatin immunoprecipitation sequencing (ChIP-seq) analyses of the binding sites of tens 
of TFs in the same cells indicating that TFs bind DNA commonly as densely packed, 
heterogenous clusters65,156. It is therefore very clear that TFs control gene regulation in a 
highly cooperative fashion. Besides cooperative interactions, TFs are also commonly 
competing with each other for the binding of overlapping or closely located binding sites, and 
all these ways of interaction are used essentially as logical operators in gene regulation. 
TFs can cooperate through many different mechanisms, the most general being the passive 
and indirect cooperativity that is based on competition of sequence specific TFs with the 
almost nonspecific binding of nucleosomes. This occurs effectively because the 
nucleosomes’ footprint of around 147 bases can easily cover several TF binding sites, and 
once a nucleosome is competed off, several target sites will be exposed nearby for other TFs 
to bind157,158. Other common mechanisms are protein-protein interactions, which occur 
commonly in many of the classical TFs. For example, most of the bZIP and all of the bHLH 
TFs can bind to DNA only as homo- or heterodimeric complexes with partners from the same 
structural class96,159. TFs have been also shown to form protein-protein interaction utilizing 
homo- and heterodimeric complexes in contexts where both of the TFs are capable of binding 
the DNA also as monomers, e.g. ETS1 can bind both as monomer or homodimer103,104. 
TFs can also cooperate by using DNA-allosteric mechanisms, where binding of one TF will 
enhance binding of another through DNA mediated means without needing direct contact 
between the proteins. These mechanisms can be roughly divided into two types; Direct DNA-
allostery (see below for references) and oscillatory DNA-allostery160.  
Direct DNA-allostery occurs if the individual specificities of two TFs overlap. In this case, 
their sites are partially truncated or merged to form a composite site. When the first of the 
TFs binds to its target region of this composite site, it changes the shape of the DNA in a way 
that supports the binding of the other TF to its respective target sequence.  
Intuitively, this kind of binding mechanism may seem unlikely, as one would expect a steric 
clash between the two TFs. However, as DNA is a helix with a full 360 degree twist every ten 
bases, a five base distance is enough to place the second TF on the opposite side of the helix, 
creating enough space for it to bind. This type of cooperativity has been observed for 
example in biochemical experiments that analyzed the binding strengths of POU2F1 TF to its 
target site in two contexts, either as an intact DBD with both its POU- and homeodomain, or 
in the case where the linker between these domains was severed showing that the two DBDs 
bind cooperatively even in the latter case and that the linker sequence strengthens the 
interaction merely by increasing the local effective concentration of the two domains161. 
Many crystal structures of multimers binding the same DNA support this mechanism, such as 
the RFX1 homodimer129, IRF multimers123-125, the SMAD3 homodimer127, the FOXO1:ETS1 
heterodimer(PDB id:4LG0, unpublished structure) and the structures of heteromultimeric 
complexes such as the enhanceosome125 as well as the ETS1-RUNX1-CBFB complex on an 
ETS1-RUNX composite site106.  
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Figure 6 | DNA allosteric cooperation between TFs 
Four X-ray structures where two TFs cooperate “through DNA” with either none or just minor contacts between 
the TFs. The PWM shown is for the same complex, except for the heterodimer example FOXO1:ETS1 (PDB 
id:4LG0) complex on the bottom, where the individual PWM models for FOXO1 and ETS1 are aligned to the 
sequence crystallized with the DBDs of these TFs. 
The oscillatory DNA allostery is much more indirect and happens when pairs of TFs 
are binding to sites that are located in a suitable distance from each other. Typically this 
distance is approximately ten bases away, and the cooperativity seems to be based on the 
thermally excited vibrational modes of the DNA. Molecular dynamics shows that the width 
of the DNA's major groove changes periodicity (~10bp) due to the vibration oscillations. 
When an external factor, such as an DNA bound TF, distorts the major groove width of the 
DNA, it will energetically favor binding of a second same kind of TF to a position that is 
located in the suitable 10bp distance away from the other TF and disfavor its binding to sites 
that are half of the distance away from it. The same phenomenon applies also to asymmetric 
TFs, when they are binding in other orientations than the direct repeat and in instances when 
two different TFs are binding to DNA. Although in these cases the distances are offset when 
compared to the ideal 10bp homodimeric case160.  
1.6.4 Regulatory code 
Detailed analyses of regulatory elements have shown large variation of their site composition, 
some of them have been shown to be of “billboard” type, where the sites occur as a collection 
of loosely packed binding sites whose orientations and spacings can be changed without 
major impact on target gene expression162. Other regulatory elements however seem to be 
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highly dependent on the concerted action of multiple specific TFs. A classical example of this 
is the interferon-β enhanceosome, where the DNA sequence is composed of a tightly packed 
assembly of overlapping composite binding sites and its function is easily disturbed by even 
small sequence changes and will drive expression efficiently only if all eight TFs are bound 
to it (125, see 163 for review). As it is becoming clear that the TFs are not limited to 
cooperation through protein-protein interactions, it is likely that these two kinds of regulatory 
elements represent extremes of the possible types and in reality the regulatory elements 
contain local regions where the TFs bind DNA cooperatively using a wide variety of 
mechanisms.  
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2 DETERMINATION OF TRANSCRIPTION FACTOR 
BINDING SPECIFICITIES  
2.1 TF BINDING SPECIFICITY MODELS 
Transcription factor specificities can be described with many different kinds of models. TFs 
typically recognise a wide range of related sequences and some of them are bound with 
higher affinities than others. TF specificities have been described using both very simple and 
very sophisticated models and there is no simple answer in respect of their superiority to each 
other. Generally speaking, more complex models are better in describing the data they were 
derived from, but on the other hand simpler models are easier to evaluate and to scrutinize for 
artefactual features such as noise or experimental bias. Additionally, simple models are 
computationally less expensive.  
Model quality is strongly affected by the way it has been generated and different algorithms 
can produce very different results from the same data due to for example the way they treat 
sequences with palindromic character. Model selection is also dependent on the kind of data, 
intended usage of the models and whether TF-specificity is approached from discriminant, 
probabilistic or physical angle164. The capability of different models to predict in vivo TF 
binding sites have been compared extensively for example in the study by Weirauch et al. 
2013, where it was shown that simple position weight matrix models (PWM) perform as well 
as more complex models for 90% of the analysed TFs165. 
2.1.1 Consensus sequence models 
The simplest way to describe the range of recognized sequences is to write it out as a string of 
letters A, C, G and T. Some more information can be added by using degenerate letters for 
positions that allow more than a single base. In the generally accepted IUPAC nomenclature 
these degenerate bases are marked with the letters that are shown in the Fig. 7166.  
2.1.2 Position weight matrix models 
The position weight matrix (PWM) is a popular format for describing TF specificities. Each 
position of the binding site for the TF is represented by the relative preference for each of the 
four possible nucleotides167. PWM models allow a more accurate representation of the 
specificities than the IUPAC bases, which is not surprising as these two models are 
equivalent except that in the IUPAC bases the values are rounded to nearest 0.33, 0.5 or 1. A 
main caveat of the PWM is that it assumes that all of the positions are independent from one 
another. Although this generalization applies remarkably well in most of the cases168, almost 
all TFs are likely to deviate from it to a small extent169. 
The PWM performs poorly in describing binding specificities of some TFs. Types of TF 
specificities that cannot be represented well with PWM are for example TFs that bind as 
dimeric complexes and allow multiple spacings and/or orientations between the binding sites. 
Examples of this kind of TFs include all members of the families AP2170 and RFX130.  
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The second category in which PWMs perform poorly are TFs that have strong 
interdependencies between their recognized bases. The independence assumption is usually 
more valid on the cases where the TF recognizes its bases predominantly by using direct 
readout mechanisms, i.e. bases are contacted directly by amino acid residues of the TF, and 
less valid when the recognition is based on DNA shape based readout of the DNA sequence 
rather than direct base contacts (see152 and the previous chapters for details).  
2.1.3 k-mer based models 
The sites that TFs bind are linear sequences of DNA, and a straightforward way to model the 
bound sites is to describe the data as a collection of fixed length sequences that can be bound 
by the TF. Each of the sequences is scored based on the evidence obtained from experimental 
data. This model has been used mainly in describing the TF-specificity data generated from 
protein binding microarrays (PBM) because fairly large datasets are required to make k-mer 
tables of high coverage73,82. Such k-mer tables can, and have been also generated using our 
HT-SELEX data, although the PBM generated tables were better in this respect due to 
insufficient sequencing coverage of our published dataset171. The main drawback of the k-
mer tables is that they are usually much shorter than the target sites (typically used as 8-mers) 
and thus they predict relatively high scores to partial matches to the binding sites that actually 
cannot be bound by the TF. This problem could be circumvented by using longer k-mers, 
such as 10-mers, or ideally as long as the binding specificity of the TF but no current 
technology can provide full coverage k-mer tables of such length. In a recent study that 
compared different types of models, the 8-mer based approaches did not fare better in the 
prediction of TF bound genomic target sites than PWM based approaches165.  
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Figure 7 | TF DNA-binding specificity models 
The specificity of HOXB13 is shown in six different types of models a) A single target site or a IUPAC 
degenerate consensus sequence. The box inset displays all possible degenerate IUPAC bases for the different 
DNA bases166., b) A single PWM shown as a logo representation (top) and as the actual matrix (bottom), c) 
Multiple PWMs, d) A k-mer table. Scatterplots of expected vs. observed k-mer frequencies are shown for each 
PWM and for the combination of the two PWMs used in the multiple PWM approach, where the reads are 
scored based on the PWM that gives higher score. The k-mers used for drawing the scatterplots and for 
calculating the Pearson correlations shown in them is the same PWM aligning subset (all 9-mers with a constant 
TAAAA sequence on the right side) of the k-mers that has the highest 24 of its k-mers in the ”k-mer table”. Note 
that while single PWM approach predicts much too large relative affinities for many of the subsequences while 
the multi PWM provides astonishingly good correlation. 
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2.1.4 Other types of models 
As neither PWM nor k-mer based methods are ideal, other kinds of models have been 
developed, but none of them have yet gained high popularity. Some models are based on 
using multiple PWMs172, or a model that connects two PWMs with linkers of defined length 
to make better models for TFs that bind as dimers with multiple allowed spacings173. Other 
approaches have been based on PWM-like feature based approaches that take into account 
the significant di- and tri-nucleotide correlations between bases174-176. Even more complex 
models have been suggested, such as Markov chains that extend the PWM (which is a zero 
order Markov model) by making each position dependent on the value of one or more 
previous positions177,165. A similar model, the adjacent dinucleotide matrix, was also 
described in Study II. 
2.2 METHODS FOR SOLVING TF BINDING SPECIFICITY 
TF binding can be analyzed both in in vivo and in vitro, and these should not be seen as 
competing but complementary approaches. In vivo approaches are observations of a highly 
complex system and as such cannot be used to explain the functions of the individual 
components in it. In vivo methodology is not the primary focus of this thesis and is discussed 
only briefly. In vitro methodology on the other hand has a central role, as the focus of all 
these studies is on in vitro analyses of TF function.  
2.2.1 Methods for in vivo observations of TF binding 
Some in vivo assays can provide information on the level of the entire analyzed system such 
as a cell line or particular tissue. Methods like DNAse-seq178, FAIRE-seq179 and ATAC-
seq180 are all used to determine the accessible, and thus active genomic regions by assaying 
either the susceptibility of the chromatin to digestion with DNAse I; the degree to which the 
chromatin gets crosslinked to nucleosomes when the cells are treated with formaldehyde; or 
is the chromatin accessible to a transposase enzyme. 
More detailed information for particular chromatin associated proteins can be gained through 
chromatin immunoprecipitation based assays such as ChIP-chip/seq/exo181,182, where the 
proteins of the chromatin are covalently crosslinked to its DNA using formaldehyde, 
followed by chromatin fragmentation and affinity purification of the desired protein together 
with the DNA fragments it is bound to. These methods are used to provide valuable snapshot-
like observations of all genomic regions bound by an individual chromatin associated protein. 
Notably, ChIP-assays are not limited to analyses of sequence specific proteins, but have also 
been used to characterize genomic features such as histone modifications (reviewed for 
example in14,15). 
Various methods have been also developed to map the three-dimensional organization of the 
genome by analysing how close genomic sequences are to each other when packed into the 
nucleus. Chromatin Conformation Capture (3C183), Circular-3C (4C184), Carbon-Copy 3C 
(5C185) and massively parallel sequencing adapted 3C (HiC186) are all variations of the same 
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basic idea where the DNA of the chromatin is crosslinked into its protein components 
followed by digestion of the DNA by a restriction enzyme and re-ligation from highly diluted 
solution, or within the fixed cells59, so that the DNA strands are preferentially ligated into 
each other if they are covalently connected into the same complexes, and thus were located 
close to each other within the nucleus. Depending of the method these steps are varied to 
some degree and/or followed with different kind of steps for detection of the closely 
associated chromosomal regions, such as gel-electrophoresis, microarray-analysis or 
massively parallel sequencing. In a variant method called ChIA-PET these procedures are 
combined with additional chromatin immunoprecipitation step to gain selective coverage of 
interconnected regions that were associated to a certain protein187. 
2.2.2 Complementary methods for analysis of TF functions 
Complementary types of methods analyze the genomic or synthetic DNA sequences for their 
ability to control the gene expression rates. Some assays measure the amount of mRNA 
molecules within the cells of interest by purifying the mRNA molecules, converting them 
into complementary DNA (cDNA) and then measuring the numbers of these molecules. In 
earlier days, and in some contexts still today, the molecule numbers were analyzed only for a 
few genes of interest using quantitative PCR based methods188, but since the current DNA 
sequencers are capable of efficient sampling of the generated total pool of RNA, it is getting 
very popular to perform these kind of analyses, as they can reveal copy numbers for large 
amount of different transcripts. These RNA-seq assays can operate even from raw material of 
a single cell189. Besides assays that analyze the function of the genes in their native state there 
are systems that are used for classification of isolated gene regulatory elements. Good 
examples of these are the classical reporter assays, where the region of interest is cloned into 
a plasmid that contains a reporter gene such as a selection marker, fluorescent- or luminescent 
protein190. A modern variant of these assays is the STARR-seq assay, where the putative gene 
regulatory sequences are used as a library that is cloned in front of a minimal promoter and 
the expression rates of the regulatory elements in the library are read from the read counts of 
transcripts that contain the cloned fragment191. 
2.2.3 In vitro methods 
Some of the in vitro methods can be used for determining TF specificities de novo – in 
essence to find the information for TFs where there was no previous available information of 
its specificity, while the others are useful in refining available specificity information. Despite 
their ripe age some historical methods are still popular, partially because of reviewers’ 
demands, but also because some have reincarnated as modernized versions or as steps of 
modern assays.  
One of the first methods that were used to study TF-specificities was footprinting, which is 
based on the idea that a DNA binding protein will protect the underlying region of DNA from 
being cut by agents such as DNAse I or hydroxyl radicals. On original form of the assay this 
protection was observed by running the partially digested and radiolabeled DNA alongside 
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sequencing gel so that the sequence of the protected region could be seen simply by 
comparing these two lanes192-194. The principle is still used in the form of DNAse I 
hypersensitivity assays, where the isolated chromatin is subjected to DNAse I digestion, 
which is then followed by massively parallel sequencing of the solubilized chromatin. 
DNAse I hypersensitivity is valuable assay as it reveals the positions of the active gene 
regulatory regions and the footprints of the TFs and it has been used to characterize a large 
number of different cell lines45.  
Filter binding assays were based on the fact that DNA does not bind to nitrocellulose 
membranes but protein does, and thus it provided a handy matrix for detection of protein 
bound DNA molecules that were usually labelled with radioactive isotopes. The method was 
used either to compare candidate sequences against each other, or in conjunction with in vitro 
selection assays (see below) (reviewed in195).  
Electrophoretic mobility shift assays (EMSA) are based on the finding that electrophoretic 
mobility of a protein bound DNA-fragment is reduced when compared to the free DNA and 
this can be used as a way to separate protein bound- and free DNA fractions from each other 
196-198(see199 for a recent review). Two old in vitro method types, one-hybrid experiments200 
and systematic evolution of ligands by exponential enrichment (SELEX)201,202have also been 
adapted to modern high throughput methods and these will be discussed in detail in later 
chapters along with a third method, protein binding microarrays (PBM).
2.2.3.1 Methods for refinement of existing TF-specificity information 
Once the binding specificity of a TF has been solved with e.g. one of the previously described 
assays, there are other types of methods that can be used to refine the information to get more 
accurate measurements of relative affinities to different sites. One way to evaluate the relative 
affinities of two different DNA molecules to a TF are competition assays. Known quantities 
of the two DNA oligomers are incubated with the TF followed by separation of the free and 
protein bound DNA and quantification of one of the two sequence species. Traditionally, the 
separation step was performed with filter-binding or EMSA but our laboratory has developed 
a more practical and accurate method for simultaneous comparison of tens of different 
sequences on affinity coated microwell plates using luciferase conjugated fusion proteins203. 
This microwell based competition assay can measure the relative binding affinity of any 
DNA-fragment against a reference DNA by competing these two species against each other. 
The binding affinity matrix is calculated from results of multiple parallel competition 
experiments, where the reference sequence (strongest target sequence) is compared against a 
variant in separate reactions. Models generated by competition assays are very reliable if the 
reference sequence is correct and if there are no significant interdependencies between the 
base positions of the TF binding, but when the reference sequence is incorrect or the site has 
interdependent base positions the competition assay will yield biased or partial models, 
respectively. The assay was used initially to characterize specificities of a few clinically 
important TFs204 and then to systematically characterize the binding specificities of all TFs of 
the ETS-class81. 
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2.2.3.2 Measurement of TF binding affinities 
Binding affinities of TF to target sites can be measured by several methods. Best 
measurement of the interaction between TF and its target site is the actual physical binding 
constant and there are multiple assays that can be used to solve this property with various 
levels of accuracy, such as; EMSA or filter binding assay that can be used for rough 
estimation of binding affinity constants by running parallel reactions with a range of 
concentrations, isothermal titration calorimetry (ITC)205 that quantifies the energy released as 
heat when one of the partner molecules is titrated into the solution of the other, microscale 
thermophoresis (MST) that can quantify the fraction of free DNA or protein in relation to 
their complex due to their different mobilities in microscopic thermal gradients206 or surface 
plasmon resonance (SPR), which measures absorption of molecules to a thin metal sheet that 
is coated with the other interacting molecule, by detecting the angle where light of certain 
wavelength gets absorbed into the surface instead of being reflected from it. All of these 
methods are laborious, difficult, expensive and/or capable of running samples only in very 
limited throughput. A few methods have been developed that could potentially determine 
binding affinities in reasonable throughput, such as microfluidics based assay based on 
instantaneous separation of free and protein bound DNA fractions followed by fluorescence 
based quantification of the bound molecules (MITOMI207) or SPR microarray that can 
analyse in parallel the interaction of a single TF with tens of different target sequences208. 
2.2.3.3 Modern high throughput methods 
Like many other branches of the biosciences the analysis of TF binding has recently 
undergone two technological revolutions, first through the development of microarrays and 
then by the massively parallel sequencing technologies. These inventions lead into the three 
main modern in vitro TF-specificity recognition methods, Protein Binding Microarray 
(PBM), high-throughput SELEX as used here (HT-SELEX) and bacterial one hybrid (B1H).  
PBMs are glass slides with 40,000 printed spots of 60 bases long individual single stranded 
oligonucleotides that have been designed to contain all possible 10-mers at least once. This 
microarray is converted into double-stranded DNA by synthesis of the second strand, which 
is then followed by binding of an epitope tagged TF construct, washing, and fluorescence 
based quantification of the amount of protein bound to the individual spots209-211. A similar 
approach, cognate site identifier (CSI), differs from the PBM in the way that the sequences on 
the microarray form the double-stranded DNA through making a loop on the center and self-
annealing. This method has been used for solving the specificities DNA binding small 
molecules rather than TFs212.  
In SELEX assays the DNA-binding proteins are incubated with double-stranded DNA oligos 
composed of random sequence that is flanked by constant amplification regions, allowing 
different DNA “ligands” to compete for binding to recombinant protein. After the binding 
step the protein bound oligomers are separated from free DNA either by EMSA or by affinity 
purification of the proteins. Protein bound DNA-oligomers are then multiplied by PCR, 
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purified and then used as a new ligand-pool for another cycle of selection. Each round of 
purification followed by PCR enriches sequences in a manner related to their affinity towards 
the ligands, i.e. a sequence which has 10-fold lower affinity to a TF than the sequence with 
highest affinity will be present at 10-fold lower concentration after the first cycle, and 100-
fold lower concentration after the second cycle201,202. 
Bacterial one hybrid (B1H) is based on two kinds of plasmids. One plasmid type is used as a 
library of plasmids that is generated by cloning short pieces of randomized DNA into a 
plasmid position that is located just before a minimal promoter sequence. This minimal 
promoter is designed to be by itself able to drive just very weak transcription rate, and thus it 
requires additional TF-sites present in subset of the cloned random sequences to drive 
effective transcription. In the plasmid this promoter drives transcription of an mRNA 
sequence that contains two bacterial strain and growth condition specific selection marker 
genes. One of the selection markers codes for a bacterial protein that can be used for negative 
selection (kills the bacteria) and the other one can be used for positive selection (bacteria stay 
alive) of sequences that activate the promoter. The second plasmid type codes for the DNA 
binding domain of the desired protein fused to a partial bacterial RNA polymerase213.  
As an initial phase of the B1H experiment the clone library is used to transform bacteria 
which are then grown in counterselection conditions designed to kill the bacteria that contain 
plasmids with self-activating sequences that can drive expression of the promoter using the 
bacteria’s own TFs. In the following stage, the actual selection is performed by transforming 
the bacteria also with the second plasmid and performing selection in a different kind of 
medium, where the survival of the bacteria is dependent on the promoter driven expression of 
the positive selection marker on the first plasmid213.  
B1H has been used primarily in Scott A. Wolfe’s lab for modeling the specificities of TFs of 
the fruit fly Drosophila melanogaster. First, 84 Drosophila homeodomains214 were modeled, 
followed by 35 TFs regulating Drosophila segmentation215 and finally 129 zinc finger C2H2 
TFs216. 
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3 AIMS OF THE STUDY 
All three studies included in this thesis aim at the generation of information about the DNA 
binding-specificities of TFs. From the beginning the purpose was to be able to perform the 
analyses on the scale of hundreds of TFs using partially automatic pipelines. 
Information on TF binding specificities is required for understanding the function of 
the genome. Without this information, we cannot decipher the language of the gene 
regulatory regions that determine when, where and how much the genes are expressed. 
Furthermore, the blueprints of the animals are also encoded in the 10-20% of the genome that 
contains the gene regulatory elements and we need the TF binding-specificities to understand 
what makes the already sequenced 119 vertebrate species different from each other and 
ourselves. The specific aims were: 
1) Develop a new high-throughput method for TF-binding specificity determination. 
2) Apply the method to solve binding specificities of as many human TFs as 
possible. 
3)  Study the evolutionary relationships of the DNA binding specificities of TFs by 
comparing data from human and from the insect model organism Drosophila 
melanogaster.  
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4 MATERIALS AND METHODS 
 
Method Study 
Cell culture and transfection I,II,III 
Chromatin immunoprecipitation I,II,III 
HT-SELEX I,II,III 
HT-SELEX data analysis based on autoseed program I,II,III 
HT-SELEX data analysis based on IniMotif program I,II 
In silico analysis of genomic enrichment I,II,III 
Laboratory automation II,III 
Massively parallel sequencing with Illumina Genome analyzer I,II,III 
Real time quantitative PCR II,III 
Recombinant DNA techniques I,II,III 
Recombinant protein production in Escherichia coli II,III 
Recombinant protein production in mammalian cells I,II 
 
Data deposition 
All Illumina sequencing reads connected to SELEX and ChIP-seq samples were deposited 
into either as a supplementary file that is located on the server of the journal Genome 
Research (Study I) or into ENA (European Nucleotide Archive), under accession numbers 
SRA012198 (Study I, ChIP-seq), ERP001824 (Study II, HT-SELEX), ERP001826 (Study II, 
ChIP-seq) and PRJEB7373 (Study III, HT-SELEX). 
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5 RESULTS 
5.1 STUDY I: MULTIPLEXED MASSIVELY PARALLEL SELEX FOR 
CHARACTERIZATION OF HUMAN TRANSCRIPTION FACTOR BINDING 
SPECIFICITIES 
This study was about the development of our novel HT-SELEX assay, which is essentially a 
high throughput adaptation of the classical SELEX method. In HT-SELEX, several of the 
bottlenecks of the original approach have been streamlined to allow studying TF specificities 
on a genomic scale. Mammalian expression plasmids were designed that allow the expression 
of TFs as constructs with Gaussia princeps luciferase and a streptavidin-binding peptide 
epitope. This design allows easy quantification of the yields of the TF fusion proteins and 
their convenient immobilization and purification using a wide variety of commonly available 
streptavidin based affinity matrices. The design made it also possible for us to convert the 
assay for laboratory automatization in Study II, increasing the possible throughput even 
further. Selection ligands were designed such that they were directly compatible with 
multiplexed massively parallel sequencing, which makes it possible and economically 
feasible to run the entire assay in batches of hundreds of TF constructs. 
 
Figure 8 | HT-SELEX design 
a) The selection ligands contain a barcode sequence that allows identification of the samples after multiplexed 
sequencing. Each well of the 96-well plate contains a ligand with a different barcode and thus represents an 
independent experiment. b) HT-SELEX is performed in a cyclical manner; the recombinant TF fusion is 
immobilized onto a solid support that is either the bottom of an affinity matrix coated plate or beads, followed by 
addition of the selection ligand. The reaction is incubated to allow the TF to find and bind to its preferred target 
sites from within the randomized part of the ligands. In the next step, the solid support is washed to remove 
unbound ligands. Protein-bound ligands are eluted from the solid support by heating to denature the TFs. Eluted 
ligands are then amplified with PCR to form the new pool of sequences which is either used for a further cycle of 
SELEX or for massively parallel sequencing. The figure is modified from213. 
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The HT-SELEX assays that were run to test the assay yielded robust data for over hundred 
TFs, out of which we published PWM models covering 18 TFs from 14 out of the main 31 
structural classes. In a successful HT-SELEX experiment, the fractions of the reads increase 
in each cycle until finally, if the selection would be carried out far enough, only a single or 
very few sequences would remain (See figure 9, below). However, in practice only four or 
less cycles need to be carried out to reach enrichment that is sufficient for the generation of 
PWM models. 
 
Figure 9 | Enrichment of subsequences 
a) PWM models constructed for the indicated TFs and selection cycles using the same seed sequences. TCF4 
was run in two replicate experiments. b) The graph shows the fraction of total reads that are described by the TF 
consensus binding sequence as a function of the selection cycle. The figure is modified from213. 
The obtained data was compared to previous findings in the literature and also with in vivo 
data obtained from ChIP-seq experiments that we carried out to validate some of the 
findings73,82,130,170,217. The produced PWM models were in very good agreement when 
compared against high quality models gathered from reliable sources, such as the ETS-factor-
profiles evaluated independently by multiple different methods (ChIP-seq, PBM and 
microplate binding assay)81. The conclusion was that the HT-SELEX is efficient and reliable 
method for determination of the TF binding specificities.  
The PWMs were generated in this study using a novel background corrected multinomial-1 
based algorithm. The multinomial-1 approach generates the PWMs based on the seed 
sequence and all of the sequences that differ from it by substitution of a single base. The seed 
sequence is usually the most enriched sequence that covers all of the base positions that 
contribute significantly to the binding specificity. This is a very simple strategy of PWM 
generation, and follows exactly the independence assumption that is an inherent property of 
PWM models. As a drawback, the multinomial-1 method requires much higher numbers of 
sequences than the traditional alignment based methods, as it discards a lot of the enriched 
signal. On the other hand, the traditional alignment based methods lead to data overfitting and 
thus essentially any seeded sequence would yield a motif even when there is no real signal (if 
a sufficient number of reads are available). Additionally, the overfitting caused by the 
alignment based methods will make the real signal overtly stringent when compared to the 
physical binding affinities (See Fig 10). 
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Figure 10 | Alignment vs. multinomial-1 PWM generation 
Figure shows how the multinomial-1 algorithm is used to generate the PWM by counting the occurrences of 
each base at a given position when all other bases exactly match a seed sequence. Note that usage of simple 
alignment would generate an excessively stringent model, even when analyzing random sequences of the 
SELEX input library, while multinomial alignment does not. The figure is adapted from72. 
5.2 STUDY II: DNA-BINDING SPECIFICITIES OF HUMAN TRANSCRIPTION 
FACTORS 
Study II applied the assay developed in the Study I for the analysis of a much larger number 
of TFs. We cloned collections of TFs and their DBDs from human and mouse into the 
pDEST40-HTSELEX (Made in Study I) or pETG20A218 vectors for expression in human 
embryonic kidney derived 293FT cells or in E. coli bacterial expression system, respectively 
and performed the HT-SELEX with the produced fusion proteins. The analysis yielded 831 
PWM models describing the binding specificities of 411 TFs representing almost all 
structural classes occurring in mammals.  
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Figure 11 | Coverage of TF specificities determined using HT-SELEX and PBM. 
The coverage of HT-SELEX and PBM based models for different structural classes of TFs are shown. While the 
coverage is similar for TFs that bind as monomers (panel a), HT-SELEX has much higher coverage for TFs that 
bind as multimers (panel b). The figure is adapted from72. 
Comparison of the PWM models generated using the three different types of clones (human 
DBDs, human full length TFs, and mouse DBDs) showed that the PWMs were essentially 
identical when comparing either the pairs of PWMs derived using the two human clone types 
or when comparing the PWMs for the human TFs and their mouse orthologs. These findings 
support the notion that TFs are highly modular proteins, and that evolutionary conservation of 
TF specificities in mammals is very high.  
As seen in Study I, many of the TFs that were thought to bind as monomers bound DNA also 
as cooperative complexes of two or more proteins. This cooperative, multimeric binding 
revealed that TFs that bound very similar sites as monomers recognized different target 
sequences when binding the DNA as cooperative complexes. Some of the TFs displayed even 
“latent specificities” when binding as homodimers, meaning that the individual specificities 
of some of the paralogs, such as the ETS factors ERG and ELK1, were changed when they 
bound their preferred sites that were occurring in closely packed “overlapping” spacing and 
orientation configurations (see also219). 
In contrast to previous work performed using PBM technology, where occurrence of 
nucleotides in different positions of recognized sequence was often interdependent leading to 
primary and secondary PWM for most of the TFs73, our analysis showed that the majority of 
the TFs bind DNA in a highly position independent fashion. In most of the cases where 
multiple PWMs were required for description of the TF’s specificities, this was due to the 
presence of both mono- and multimeric binding configurations, or of dimers with multiple 
accepted orientation and spacing combinations between the individual sites. However, we 
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observed some notable exceptions where the TFs required multiple PWM models even 
though their recognized sites did not display obviously multimeric character. 
Systematic analysis of all bases in all PWMs showed that in most of the cases the base 
interdependencies occurred on adjacent nucleotides. This suggests that these dinucleotide 
preferences are based on DNA shape recognition based mechanisms. All 16 combinations of 
adjacent DNA basepairs have distinct shape and deformability properties, and the TFs can 
recognize sequences indirectly by forming shape dependent contacts to the backbone and the 
minor groove of the DNA. In many cases, such dinucleotide correlations were visible through 
enrichment of poly A or T stretches, which are often recognized by arginine residues that 
insert into the narrowed minor groove typical for poly A or T152. Some other TFs however 
bound sites that had more distinct types of base interdependencies. For example all four 
HOX13 TFs bound two sites with CTCGTAAA or CCAATAAA consensus sequences with a 
very strong trinucleotide correlation. 
We experimented also with two novel kinds of models for description of the specificities of 
the TFs that cannot be described well using a single PWM. The first of these two models, the 
adjacent dinucleotide model, takes into account the effect of dinucleotide-level correlations 
between the adjacent bases. This type of model is well suited for the description of 
specificities of TFs like E2F3, which binds as homodimer and whose core sequence is 
flanked on either side by approximately four bases long stretches of A or T (Fig 12a). The 
second model on the other hand, the connecting matrix model, is intended for the description 
of TFs, such as T-box TF TBX20 that can bind as homodimers with multiple spacing and 
orientation combinations. In the connecting matrix model the data is represented by 
combining the monomeric specificity describing PWM of the TF with connecting matrix that 
gives rank and weight to the different spacing and orientation observations (Fig 12b). 
 
 
Figure 12 | Adjacent dinucleotide and connecting matrix models 
a) The adjacent dinucleotide model describes TF specificity as probabilities that a base is located next to another. 
In the shown logo representation the overrepresented dinucleotides are indicated by black bars and gray bars 
represent dinucleotides that are not overrepresented when compared to expected (based on positional 
independence assumption). Width of the bars represents the frequency of the indicated dinucleotide. b) The 
connecting matrix model consists of a monomer PWM (monomeric site of T box TF TBX20 indicated by red 
arrow) and a matrix that describes spacing and orientation preferences of two such sites. The heatmap indicates 
that for this TF the preferred orientation and spacing configuration is when the two sites are in the same 
orientation and separated by an eight bases long gap. The figure is adapted from72.  
  55 
 
 
5.3 STUDY III. THE CONSERVATION OF TRANSCRIPTION FACTOR BINDING 
SPECIFICITIES ACROSS 600 MILLION YEARS OF BILATERIA 
EVOLUTION 
In the previous study we had analyzed difference between mouse and human TFs and found 
no clear cases of changed specificities between pairs of directly orthologous TFs from these 
two species. This was perhaps not very surprising for the researchers who work in the field of 
TF specificities. After all mouse and human are close relatives when it comes to molecular 
evolution and the amino-acid sequences of DBD regions are very conserved between these 
two species.  
Thus, to provide answers to the question of evolutionary conservation, we applied the HT-
SELEX for analysis of binding specificities of Drosophila melanogaster TFs, with which our 
lineage shared a common ancestor over 600 million years ago. Reasons for the selection of 
this species was because of this long evolutionary distance and the fact that Drosophila is an 
extensively researched model organism especially in the field of developmental biology. 
The clones for the Drosophila DBDs or full length TFs were obtained from collaborators in 
Eileen Furlong’s and Max Deplancke’s groups or ordered as synthetic genes. The TFs were 
produced as fusion proteins using the same E. coli expression based protocol as was used in 
Study II for a subset of the analyzed TFs. Overall we obtained PWMs for 242 TFs of 
Drosophila melanogaster describing specificities for representatives of almost all of the TF 
families expressed in it. 
 
Figure 13 | Coverage of Drosophila TF specificities 
The obtained coverage of HT-SELEX models for different structural classes of predicted Drosophila 
melanogaster TFs is shown Figure is adapted from220. 
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Comparison of the fruit fly PWM dataset generated in this study against the human and 
mouse data derived from Study II revealed a surprisingly high level of conservation of the 
sequence specificities of TFs. In most cases, the fruit fly TFs bound almost identical target 
sites as their mammalian counterparts. Observed conservation of the binding specificities 
extended even to subtle dinucleotide preferences. Thus, it seems that the primary target 
specificities are under very strong selection pressures and have been kept remarkably 
constant. However, mammalian genomes code for many more sequence specific TFs (around 
1400) than the fruit fly (around 400-700), and both of the lineages contain a few types of TFs 
that have evolved after the lineages split and that thus recognize sequences used only in the 
respective lineages. These include several structural classes that appear to be used in only one 
of the species, such as brinker TFs in Drosophila and IRF TFs in human. Additionally there 
were new subfamilies of shared structural classes that only occurred in one of the species, 
such as the ETS class III that has three TFs in human and has evolved different specificity in 
the form of an A-stack on the 5’ side of the canonical ETS motif. There were even a few 
cases where apparently directly paralogous TFs had diverged in specificities, such as 
Drosophila CG30420 and its human orthologue ATF7. In most of the cases where TFs had 
evolved new specificities, they were connected to cell types that were specific to that 
particular animal. 
In addition to the analysis of divergence of TF specificities, the article introduced several new 
technological innovations, such as a new distance metric “Huddinge distance” that can be 
used to find local maxima of overrepresented gapped DNA k-mers. The concept was 
implemented in two novel informatics tools, “kmerseed” and “autoseed” that allowed a much 
deeper analysis of sequence patterns than previously possible using existing tools. As these 
new methods can analyze all possible gapped or ungapped k-mers and then output the desired 
number of highest local maxima, they excel in sensitive detection of various enriched signals 
(as implemented in the program “autoseed”) and distinguishing the most relevant spacings 
and orientations between homo- or heterodimeric target sites (in “kmerseed”). 
Our data supports the view that, with the exception of the highly modular family of C2H2 
zinc fingers, the protein-DNA interactions are very resistant to evolutionary changes. Thus, 
the majority of differences in gene regulation, and thus most of the differences between two 
organisms are not in the machinery of transcriptional regulation but in the DNA-sequences 
that are read by them. Thus, analogously to the genetic code that specifies how the DNA 
sequence of the genes is converted to amino acid sequences of the proteins, the second 
genetic code that guides transcription is very similar between animals and the changes occur 
in the information itself and not in the way it is decoded in different organisms. 
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6 DISCUSSION 
Before our studies, the knowledge of TF-binding specificities was very fragmented. Most of 
the data had been generated by hundreds of individual researchers that were using a multitude 
of different methods, and in almost all of these experiments the models were based on very 
few measurements. Because of these reasons it was very hard to evaluate the quality of the 
models and comparison of different data was often very likely to reflect method specific 
biases rather than genuine differences in the binding specificities of the TFs.  
Notable exceptions to this were the previous large-scale analyses of TF specificities for 
several hundred mouse and Drosophila melanogaster TFs using PBM and B1H, 
respectively73,82,214,215,216. Additionally, our own group had analyzed the specificities of the 
entire ETS class using a microwell based competition assay81. 
The value of consistent datasets generated by the modern high throughput assays is shown 
clearly when the older models assembled from literature are compared to results from PBM, 
B1H, HT-SELEX or the microwell based competition assay81,82 (Fig 14). 
 
Figure 14 | Benefits of systematically generated datasets 
Figure compares PWM models generated systematically using three modern methods, HT-SELEX, Microwell 
based competition assay and PBM to older models collected from literature into Jaspar database217. The four 
topmost TFs belong to ETS class I and bind very similar primary PWMs based on all three modern methods. 
The PWMs assembled from the literature are on the other hand very heterogenous and analysis based on them 
would lead to false assumption that the TFs have divergent primary specificities. Note also that only the HT-
SELEX has captured the dimeric binding modes of ETS1 and ELK1 shown below the monomeric PWM, and 
that only the HT-SELEX and one of the Jaspar models (based on ChIP-seq in vivo data) have detected the “A-
stack” of SPI1. The microwell based competition assay and universal PBM cannot detect these binding modes 
because the microwell based competition requires previous information about a consensus binding site and the 
universal PBM contains only all possible 10 base long sequences. The Figure is modified from81 through 
addition of data from72. 
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6.1.1.1 Benefits of the HT-SELEX over other modern methods 
PBM method is limited mainly by its ability to cover only all up to 10 bases long possible 
sequences because the number of all possible sequences is exponentially related to the length 
of the DNA k-mer. Due to this inherent limitation the PBM often fails to model the 
specificities of the TFs that recognize long target sequences, or it ends up into generation of 
PWMs that describe poorly the specificity of the TF e.g. by modeling a subset of the target 
site (See Figure 15, below).  
 
Figure 15 | Comparison of PBM, HT-SELEX and ChIP-seq data for TFs with long specificities 
Even though the PBM method is capable of generation of accurate PWM models for certain TFs, the HT-
SELEX outperforms PBM in the cases where the TFs recognize long target sites. In the four indicated cases, the 
HT-SELEX approach leads to the generation of long target sites (>10 bp), which are similar to the sites 
generated from analysis of ChIP-seq data in the three cases where such data was available. The PBM method on 
the other hand leads to the generation of partial binding specificity models, because the method is limited by the 
coverage of long target sites. The figure is adapted from72. 
Additional drawbacks include the fact that PBM method operates a single sample at a time, 
so the throughput is low, it is fairly expensive, and it has a relatively high (µg level) demand 
for purified protein. The data generated with HT-SELEX and PBM methods have been 
compared against each other in Study II and in two independent studies171,221. Based on these 
findings, the results are mostly similar, but on closer analysis the HT-SELEX performs better 
in the prediction of in vivo targets and for TFs that have long target sites. On the other hand, 
PBMs give more robust measures for modeling of TF-specificities as 8-mers, which is likely 
due to too low sequencing coverage of the HT-SELEX ligands171,221.  
The main benefit that HT-SELEX has over B1H is that in B1H the number of molecules that 
undergo selection is practically limited by bacterial transformation efficiency (~10,000,000 
molecules). The HT-SELEX on the other hand can easily use libraries of 100 ng of DNA, 
which has several thousand times the number of the molecules used in a B1H experiment. In 
practice, the difference is even larger as the B1H clones are counter-selected before the actual 
selection step221.  
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Traditional SELEX was severely limited by the sequencing output that could be gained from 
Sanger sequencing. This was remedied to some extent by using a protocol that concatenated 
ligands from the selected pool into continuous fragments that could then be cloned and 
sequenced to gain higher coverage of ligands with fewer sequencing reads222 and finally by 
adaption of the SELEX to massively parallel sequencing simultaneously by us and others 
(Bind-n-seq223, SELEX-seq224 and HT-SELEX225).  
6.1.1.2 Cooperative binding of TFs 
All three studies showed instances where the TFs bind DNA cooperatively as 
homomultimeric complexes. Cooperative binding of TFs also often leads to recognition of 
composite sites where the two binding motifs overlap. The formation of composite site 
recognizing complexes is in most cases likely to be mediated through the DNA shape, where 
the binding of one of the TFs changes the shape of the DNA in a way that promotes the 
binding of the other TF to the adjacent position. This DNA-mediated conformational 
compatibility was observed commonly between many homodimeric pairs and is similar to 
previous observations based on analyses of crystal structures of DNA binding multiprotein 
complexes, such as the interferon-beta enhanceosome125,226. Additionally, experimental 
analyses performed on POU2F1 have shown that the two DBDs of this TF can cooperate 
through DNA even if the peptide-link between them is severed161. In many cases we also 
observed longer-range cooperativity (Figure 16b) that is likely to be based on DNA shape 
although more indirectly as it is mediated through oscillation of the vibrations in the DNA160. 
Even though many of the homodimers captured by the HT-SELEX, are mediated through a 
combination of protein-protein interactions with either of the DNA mediated mechanisms, for 
example the previously characterized homodimeric binding site of ETS1, the structure of 
which has been solved using X-ray crystallography103,104, the results suggested that the 
cooperative interactions of the DNA binding TFs are dominated by the DNA-shape based 
mechanisms.  
Orientation and spacing preferences mediated through DNA shape based cooperativity 
appear to change more often during the evolution than the primary specificities of the TFs. 
Based on the findings in Studies II and III, many of the paralogous TFs that bind highly 
similar individual sites formed homodimeric TF-complexes with different orientation and 
spacing preferences. This kind of divergence has taken place multiple times during the 
evolution and in many different structural classes, such as in ETS-, FOX- and TBX families. 
Experiments in all of the described studies analysed TFs only in individual context and the 
results were limited to homodimers, however there is no reason why the DNA-shape based 
cooperative behaviour should be limited to homodimers and thus the mechanism is very 
likely to be used commonly also in heterodimeric contexts.  
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Figure 16 | DNA shape based cooperativity (DNA allostery) 
a) Divergence of multimeric specificity in ETS class I TFs; While all of the class I ETS TFs bind highly similar 
specificity when binding the DNA individually (example PWM on top right corner), the ETS TFs ERG, ETS1 
and ELK1 have evolved to recognize different homodimeric orientation and/or spacing preferences (black 
arrows). In the ETS1 structure contacts are formed between the DBDs, while in the case of ERG and ELK1 the 
cooperativity is likely to be mediated entirely through DNA shape. On the right side of the figure the three 
structures of ETS DBDs have been aligned based on the nucleotides CCGGAA or matching positions in the 
ETS1. Structural alignment shows that the DNA has different shape in all of the structures. Note however that 
because the ETS1 has been crystallized with a different (low-affinity) target-site, it is hard to know how much of 
the shape difference is due to differences between the proteins or the inherent DNA shape. Structure of ETS1 
homodimer has been solved using X-ray crystallography while the ERG and ELK1 structures are schematic 
models based on fitting the monomeric crystal structures of the two TFs into a idealized structural model of B-
DNA103,227,228. b) Another kind of DNA allostery occurs commonly when two TFs are located longer distance 
away from each other. Above T-box TF EOMES (monomer PWM on left, the site is also indicated as s violet 
arrow in the heatmaps) displays preferential binding of the two TFs to certain spacing and orientation 
combinations that are shown as heatmap visualizations where the red color indicates the fraction of the highest 
position. In the most preferred combination of spacing and orientation the sites have 6 bases long gap between 
the individual binding sites that are oriented tail to tail. This site is shown both as a PWM and as a schematic 
model based on crystal structure of paralogous TF TBX5 (PDB:2X6V)229. Below, normalizing the read counts 
within each orientation shows that EOMES sites display spacing preferences in all of the orientations, and that at 
least in two of them this phenomenon displays periodic behavior, as there is also another preferentially bound 
region that is located approximately ten bases further from the first one. The red-bordered inset shows all 
spacings and orientations occurring in this region that are normalized against the maximum value (as in the 
upper heatmap but normalized to preferences occurring in this region). 
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The shape based mechanisms offer an easy way to evolutionary divergence of paralogous 
TFs. By using this mechanism, the TFs can retain their individual binding specificities and 
instead diverge by adjusting the way that the TF-DNA interaction changes the shape of the 
DNA. The shape change then causes the paralogs to recognize partially separate subsets of 
target sites that either of the TFs recognizes when binding with homo- or heterodimeric 
binding partners. 
6.1.1.3 Evolutionary perspective 
Study III that generated new data for the binding specificities of the fruit fly TFs and 
compared the data to data of Study II found surprisingly high conservation of TF DNA-
binding specificities. A possible explanation for this is that the functions of a TF are tied to a 
multitude of its target sites, and thus evolution of new specificities is constrained not just by 
the demands of the protein fold. On the other hand, a mutant TF that recognizes a novel 
specificity is in most of the circumstances likely to act like a loose cannon, recognizing new 
target sites that are located stochastically in random locations of the genome. 
All in all, the combined data from all of the three studies reinforce the notion that even 
though there are many known instances of proteins that have evolved into new roles in 
specific animals, evolution of complex multicellular organisms happens to a large extent at 
the level of regulatory elements and not in the protein coding sequences. This makes a lot of 
sense; proteins are intricate and fascinating things that have been optimized for their roles 
over time spans of hundreds of millions of years, but in the end each of them performs 
usually just one or few tasks.  
Beneficial mutation on a protein-coding gene itself is very unlikely because of the general 
principles of protein structure; any substitution of an amino acid to another is most likely to 
be either functionally silent or harmful. Additionally, it is very unlikely that a change in any 
given individual component would manifest as a fitness increase, as it is just one out of 
thousands and the entire organism is composed of millions of cells belonging to hundreds of 
different cell types. Mutations in regulatory elements on the other hand do not change the 
components of the cells but their quantities. In most cases, such a change would take place in 
enhancers and due to this the expression level change would be limited to a specific range of 
cell types and leave the others completely unaffected. Therefore, the probability that the 
organism tolerates the mutation is much higher when it occurs in regulatory elements rather 
than protein coding regions of the genes. 
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7 Conclusions, remarks and future prospects 
The studies described in this thesis represent an important advance in the field of 
transcriptional gene regulation. An understanding of gene regulation is of vital importance to 
essentially all fields of molecular biology and medicine, and the effect of these studies 
reaches even beyond. Furthermore, as the studies also showed the astonishing level of 
conservation of TF sequence specificities between the fruit fly and human, the results are not 
limited to our own- or even closely related species such as other mammals, but apply well to 
all forms of animals.  
It is impossible to understand gene regulation of animals without information about their gene 
regulatory components and thus the major findings presented in these studies are not any 
singular things, but the entire generated datasets composed of hundreds of models for TF 
specificities.  
7.1.1.1 Future prospects 
More studies have been planned or are already under preparation. Besides the natural follow-
up through increasing the coverage of the TF model collections there are other important 
aspects that need and can be addressed with approaches that are similar to the HT-SELEX, 
for example: Effect of CpG methylation to DNA binding; Formation and specificities of 
heterodimeric TF complexes and; studying the sequence specificity of RNA binding proteins. 
As seen throughout this thesis, structural information about the TFs and their DBDs is 
indispensable for understanding their function. Because structures of many kinds of DBDs 
are still unknown, there is a demand for large number of X-ray crystallography experiments 
to determine the structures of DBDs binding into their high affinity target site. 
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